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ABSTRACT
Investments in Electronic medical records (EMR) is one of the largest components of overall
health information technology investments. Examining the impact of EMR on quality of healthcare
delivery is a topic of significant importance. This dissertation aims at exploring the relationship
between the EMR capabilities and healthcare quality performance of hospitals. In particular, this
study examines three important issues. First, the relationship between the synergy among different
portfolios of EMR capabilities and quality of care at U.S. hospitals is studied. It also extends the
analysis of EMR capabilities effects on quality of healthcare beyond the focus on the initial
investment to examine how the assimilation and use of different EMR capabilities impact various
healthcare quality measures. We used archival data to conduct a five-year (2008-2012)
longitudinal study of a large panel of U.S. hospitals.
Second, this study seeks to determine whether early adopters of advanced EMR capabilities
(CPOE and physician documentation) were able to improve quality of healthcare, and finally, this
research also answers the question of whether EMR capabilities adoption path impacts healthcare
quality outcomes.
Our results suggest that the synergy among full EMR capabilities portfolio is associated with better
quality outcomes. Our results also suggest that the greater assimilation and use of EMR capabilities
are also associated with improvement on only one quality outcomes measure. Further, the results
highlight that early adopters of advanced EMR capabilities were able to improve quality outcomes
relative to hospitals that were not early adopters. Furthermore, our results suggest that the sequence
of EMR capabilities adoption does matter, and the findings empirically show improvement in
quality outcomes when hospitals follow certain sequences of EMR capabilities adoption. We
believe that this study has important implications for public policy focused on enhancing health
IT investments in EMR capabilities and improving quality outcomes.
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CHAPTER 1
INTRODUCTION

1.1 IT Investment in Healthcare
Many organizations increased the investment in information technology (IT) to meet the
growing demands for efficiency and effectiveness (Ghapanchi, Tavana, Khakbaz, & Low, 2012).
According to Rivard, Raymond, and Verreault (2006), well-planned investments in IT that meet
business mission requirements can have a positive impact on organizational performance. On the
other hand, poorly planned IT investments can postpone or severely limit organizational
performance (Gunasekarana, Love, Rahimic, & Miele, 2001).
In the current healthcare context, expenditures are approaching “$3 trillion and comprise
about 20 percent of U.S. economic activity” (Briggs, 2014). Berwick and Hackbarth (2012)
estimated that between $558 billion and $1264 billion of expenditures in 2011 may be considered
as waste and provided no value to patients. The expenditures that are considered wasteful include
failure in care delivery, failure of care coordination, overtreatment, administrative complexity,
pricing failure, and fraud and abuse. Organizations view investments in information technology as
a way to improve productivity, profitability, and the quality of operations (Devaraj & Kohli, 2003).
To this end, healthcare organizations continue to make investments in IT to deliver better care.
The premise is that investments in health information technology will improve healthcare
processes and raise the quality and safety of patient care leading to better outcomes by reducing
medical errors, reducing duplicate testing and overtreatment, and lowering administrative
expenses (Johnston et al., 2012).
In the U.S., hospitals have taken steps to implement various health information technologies
(HIT) in order to provide effective care that consistently results in improved outcomes. Examples
of these technologies include electronic medical records (EMR), picture archiving and
communication systems (PACS), and facilitating care from a distance. These distance technologies
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include access to medical journals and databases on the internet, videoconferencing, emails, or
feedback via the internet (Lluch, 2011).

1.2 EMR Capabilities and Healthcare
Health IT is a subset of information technology used to make a decision concerning diagnosis,
treatments, and control several medical conditions (Angst et al., 2011). Various technologies
applied to healthcare setting including computerized practitioner order entry (CPOE), clinical
decision support systems (CDSS), and EMR. EMR is one of the most important components of
health information technology and is viewed as a system that will substantially contribute to
improving quality of healthcare, patient safety, and cost effectiveness (Debbie, 2009). EMR is
known by various other names including electronic health records (EHR), electronic patient record
(EPR), and computerized patient record (CPR) (Menachemi & Brooks, 2006). In this study, the
term EMR is used to represent all such technology.
According to a report published by the Institute of Medicine (2003), EMR should be capable
of performing core related capabilities or basic functionalities in order to promote greater safety,
quality, and efficiency in health care delivery. The committee of the Institute of Medicine has
identified a set of eight core care delivery functions. These are: health information and data, result
management, order management, decision support, electronic communication and connectivity,
patient support, administrative processing and reporting, and reporting and population health
management. This was necessary in order to leverage providers’ knowledge of the functional
capabilities of EMR systems, resulting in better decisions in systems purchasing. Systems are
purchased that are more appropriate for their practice needs (Debbie, 2009).
EMR functionality is characterized by automation of patient information and medication data,
documentation, and clinical decision processes. These processes include order entry management
and support of clinical decision making (Furukawa, Raghu, & Shao, 2010b). Accordingly,
achieving true EMR functionality requires adding capabilities including: Clinical data repository
(CDR), clinical decision support systems (CDSS), computerized practitioner order entry (CPOE),
and other provider-centric information technologies (Carter, 2008). In line with these
characteristics, the Healthcare Information and Management Systems Society (HIMSS) analytics
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database1classifies EMR as a category. The following capabilities that could achieve the
aforementioned EMR core related functionalities, include but are not limited to:


CDR: CDR is a real time database that combines disparate information about patient in
single database.



CDSS: CDSS is a system that uses clinical information to help physicians diagnose
patients, and provide advises in drug selection, dosage, interaction, and allergies by
providing alerts, reminder, and recommendations based on patient history (Bates, 2010).
CDSS is also intended to ensure adherence to clinical guidelines of patient treatment.



Order Entry includes Order Communications: This provides electronic forms to streamline
hospital operations (replacing paper forms).



CPOE: CPOE is a more advanced and sophisticated type of order entry and include patient
information and clinical guidelines. This application helps physicians order drugs,
laboratory tests, and ensures the order is complete and legible.



Physician Documentation: This helps physicians complete documentation/notes
electronically in order to accurately assign diagnostic codes.

Further, as part of the Health Information Technology for Economic and Clinical Health
(HITECH), part of the American Recovery and Reinvestment Act of 2009 (ARRA), practices must
meet specific guidelines and requirements for EHR that is designed to improve patient care safety,
healthcare quality, and efficiency. Known as “Meaningful Use”2. HITECH Act supports adoption
of certified EHR and provides monetary incentives for hospitals only if specific meaningful use
requirements are met. In this context, there is lack of research that inform EMR capabilities
implementation and sequence of EMR capabilities adoption.

1.3 Research Gaps and Questions
Our goal in this study is to examine the relationship between the implementation of EMR
capabilities and patient quality of care, and to derive further insight by studying how the
complementarities among EMR capabilities impact healthcare quality. Several studies have
examined the effects of IT on organizational performance in healthcare (e.g., Briggs, 2014;

1

http://apps.himss.org/foundation/histdata.asp

2

https://www.healthit.gov
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Chaudhry et al., 2006; Devaraj & Kohli, 2003; Mccullough, Wang, Parsons, & Shih, 2015; Setia,
Setia, Krishnan, & Sambamurthy, 2011; Spaulding, Furukawa, Raghu, & Vinze, 2013). Recent
studies have reported mixed evidence on the influence of health IT on healthcare outcomes
(Bardhan & Thouin, 2013). Some studies in other industries suggest that the effects of IT varies
based on the portfolio of IT capabilities implemented and used by an organization (Aral & Weill,
2007; Dehning, Richardson, & Zmud, 2003). Although some studies have found a significant
impact of IT investment on firm performance, others have failed to do so (Devaraj & Kohli, 2003).
One explanation for the inconsistent findings is that most studies have overlooked an important
dimension that could influence the relationship between IT and firm performance. Recent studies
have argued that IT synergy has a significant role in enhancing firm performance (Cho and Shaw
2013; Tanriverdi 2005, 2006). Synergy refers to the additional expected value that can be achieved
from multiple IT capabilities investments, which cannot be obtained from stand-alone individual
technology. A firm may be able to save cost or create additional values from IT synergies
(Tanriverdi, 2005, 2006). Moreover, there is a lack of research on the impact of the synergy
between health IT systems on healthcare quality. Therefore, the objective of this study is to
advance our understanding of the impacts of the synergy between IT systems on organizational
outcomes in healthcare context. In particular, the focus of this research is on EMR’s which in
recent years has been the focus of large investments. Thus the first question addressed is whether
the synergy between different EMR capabilities yields better quality than stand-alone health IT
investments?
Next, we acknowledge prior research suggesting that technology usage is critically important
in order to leverage IT productivity improvement (Brynjolfsson, 2005). Devaraj and Kohli (2003)
have argued that investment in technology alone is not sufficient for reaping the promised benefits
of information technologies. The driver of IT’s impact on performance, however, lies in the actual
usage. IT assimilation and use are the key variables in enhancing organizational performance
(Devaraj & Kohli, 2003). Assimilation here refers to the extent of adoption and use of information
technologies within the work processes (Setia et al., 2011). Here, we address the second research
question: Does the intensity of EMR capabilities’ assimilation and use have an impact on
healthcare quality?
In the first research question, we explore the relationship between the synergy among EMR
capabilities and quality of healthcare. In the next study, we further explore this issue along the
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time dimension to explore the impact of the sequence of EMR capabilities adoption. As noted
above, poorly planned IT investments can postpone or severely limit organizational performance.
Therefore, the next research question how does the sequence of EMR capabilities adoption have
an impact on healthcare quality?
Furthermore, according to some economic studies of first-mover advantage, one way for
organizations to achieve higher returns is to seize new lucrative opportunities early. It is claimed
that only early adopters obtain a competitive advantage from IT adoption (Porter & Millar, 1985).
In a healthcare context, early adopters may both earn benefits from early investments in health IT
capabilities and may also find the optimal combination of health IT capabilities for their unique
situation. Late adopters, on the other hand, may take a longer time to mimic the early adopters’
configuration of health IT capabilities to see similar results (Pye, Rai, & Baird, 2014). Therefore,
in this study we also examine the effects of adoption timing associated with EMR capabilities.
Accordingly, our fourth research question is whether early adoption of EMR capabilities have an
impact on healthcare quality?
1.4 Outline of Dissertation
This dissertation has the following organization. Chapter 2, is literature review and includes
a summary of the research studies on health IT and quality of healthcare. Chapter 3 describes the
research objectives and the research model. Chapter 4 describes the research methodology
including statistical model specifications, data sources, and study variables. Chapter 5 discusses
the results and the dissertation concludes with Chapter 6, which includes a summary of research
contribution and impact, discussion of study limitations, and suggestions for areas of future
research.
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CHAPTER 2
LITERATURE REVIEW
2.1 Health IT and Quality
In this chapter, we review relevant research on health IT and its impact on healthcare quality
outcomes and identify research gaps that lead to our research objectives. The literature is organized
into two categories: (1) Research studies that examine the impact of individual health IT systems
on healthcare outcomes as shown in Table 1, (2) Research studies that assess the impact of health
IT portfolios on healthcare outcomes as shown in Table 2.
Table 1 summarizes the studies that assess the effects of health IT on healthcare quality
organized by the most investigated health technologies including EMR, clinical decision support
systems (CDSS), and computerized practitioner order entry (CPOE).
Quality is an important, and sometimes overlooked, dimension in the debate over healthcare
reform (Bardhan & Thouin, 2013), especially since health information technologies have the
potential to improve both the quality of healthcare processes (Bardhan & Thouin, 2013; David
Bates, 2002) and outcomes (Bélanger, Bartlett, Dawes, Rodríguez, & Hasson-Gidoni, 2012).
A growing body of research investigates the impact of health IT on various aspects of
healthcare quality. Menon and Kohli (2013) studied the relationship between health IT expenditure
and quality of patient care using readmission and mortality rates measures. The study found that
health IT is associated with lower readmission and lower mortality rates resulting in higher quality
of care. Similar significant association between IT expenditures and lower mortality rates are
observed by Gholami, Higón, and Emrouznejad (2015). Amarasingham, Plantinga, Diener-West,
Gaskin, and Powe (2009) investigated the influence of the level of automation on healthcare
outcomes. Hospital automation areas include test results, notes and records, order entry, and
decision support. The outcome measures used in the study are inpatient mortality, complications,
and length of stay. Hospitals with more health IT systems are associated with lower levels of
inpatient mortality and complication. However, no clear effect of health IT was noted for length
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of stay. Other studies, on the other hand, found that the effect of computerization on process quality
measures such as myocardial infraction, heart failure, and pneumonia made little difference in
quality (Himmelstein, Wright, & Woolhandler, 2010).

Several studies investigate the influence of EMR on various healthcare quality measures.
Linder, Ma, Bates, Middleton, and Stafford (2007) conducted a national cross-sectional study to
assess the association between EHR implementation and quality of ambulatory care. The results
showed that for 14 of 17 quality indicators, there was no significant difference in performance
between visits with and without EHR. These quality measures assess whether patients received
recommended care and included indicators such as medical management of common diseases,
recommended antibiotic prescribing, preventive counseling, screening tests, and avoiding
potentially inappropriate medication prescriptions for the elderly.
McCullough et al. (2015) examined the impact of the transition from paper recordkeeping to
EHR use on practice-level performance of nine clinical quality measures. The measures include
both process and outcome measures such as antithrombotic therapy, body mass index (BMI)
recorded, smoking status recorded, smoking cessation intervention offered, hemoglobin A1c
(HbA1c) testing and control, cholesterol testing and control, and blood pressure control. The
results showed that the effect of EHR adoption on performance on clinical quality measures is
mixed. Lee, Kuo, and Goodwin (2013) assessed the relationship between basic EMR adoption and
30-day re-hospitalization, 30-day mortality, inpatient mortality and length of stay. In particular,
they compared the outcomes of hospitalization before and after EMR adoption among hospitals
that adopted EMR. The results showed small but statistically significant association of EMR
adoption with healthcare outcomes.
O’Connor et al. (2005) conducted a 5-year longitudinal study and assessed the impact of EMR
on diabetes quality of care. The study compared one practice with EMR and one practice without
EMR. The processes and outcomes measures used are glycated hemoglobin (HbA1c) and lowdensity lipoprotein (LDL). The frequency of HbA1c tests improved in the practice with EMR
compared with the frequency at non-EMR clinic. Similar results were noted for LDL levels.
Parente and McCullough (2009) estimated the impact of ITs on some patient safety measures
using panel data analysis approach. They examined EMR, nurse charts, and PACS. The safety
outcomes measures are infection from medical care, postoperative hemorrhage, and postoperative
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pulmonary embolism. The results showed that EMR is associated with positive effect on patient
safety measures.
Others studies also showed that the impact of EMR on healthcare quality varies by measures,
has no significant difference between practices with and without EMR, or has no statistically
significant association with quality (Adams, Mann, & Bauchner, 2003; DesRoches et al., 2010;
Romano & Stafford, 2011).
Overall, we observe that these studies have reported conflicting findings on the impact of
EMR on the quality of patient care. Basically, these studies have reported mixed evidence on the
influence of EMR on healthcare outcomes. On the other hand, in spite of a large volume of studies
that investigated the influence of EMR on healthcare quality, there is a shortage of research that
empirically examines the implementation of different EMR capabilities and their impact on the
quality of healthcare.
Based on the systematic review of 257 published studies on the impact of health IT between
1995 and 2005, Chaudhry et al. (2006) reported on the major effect of health IT on various
measures of quality of care. Most of the reviewed studies examined DSS and EHR. The systematic
review found that well-implemented decision support systems can yield real benefits in terms of
improvements in adherence to guidelines, enhanced monitoring and surveillance activities, and
reduction in medication errors. In 2011, Jaspers, Smeulers, Vermeulen, and Peute conducted a
systematic review on the effect of CDS systems on patient outcomes and practitioner performance.
The results showed that 30 percent of the examined studies had a significant impact on patient
outcomes and 57 percent on practitioner performance. Preventive care reminders and drug
prescription system were the areas that CDS systems has the greatest impact. Romano and Stafford
(2011) also investigated the impact of CDS on healthcare quality and reported that CDS had a
significant positive impact on only one of 20 quality measures.
Overall, we note that these studies assessed the impact of one EMR capabilities on healthcare
quality. Therefore, there is a lack of research that capture all EMR capabilities and their impact on
patient quality of care.

A recent study conducted by Jones, Rudin, Perry, and Shekelle (2014) consists of a systematic
review of 147 studies on the 170 key quality-related outcomes (care process, health outcomes, and
patient or provider satisfaction) between 1995 and 2013. Most of the evaluation focused on clinical
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decision support (CDS) and computerized provider order entry (CPOE). The reported results
showed: 1) Most studies of CDS have reported positive or mixed-positive results with respect to
the improvements in the processes targeted by decision support; 2) Most evaluation of CPOE have
reported positive or mixed-positive effects with respect to medication error reduction; and 3) A
small proportion of studies reported neutral or negative results due to a particular intervention,
context, or implementation. Kaushal, Shojania, and Bates (2003) performed a systematic review
to examine the impact of CDS and CPOE on medication safety. Four studies showed
improvements in adverse drug events and medication errors while three studies demonstrated
statistically insignificant results. Radley et al. (2013) used a systematic review and hospital survey
data on CPOE implementation in order to estimate medication errors reduction in hospitals that
adopted CPOE in 2008. The results showed that the use of CPOE decreased the likelihood of a
prescription drug order error by 48 percent.
We observe that the aforementioned studies focused on specific health IT capabilities rather
than portfolios of capabilities and their impact on healthcare quality outcomes. Our research, in
contrast, aims at investigating the impact of portfolios of different EMR capabilities on quality of
care using panel data analysis.

Table 1. Individual Health IT Systems
Study

Description

Results

EMR and Healthcare Quality
(Mccullough et al.,
2015)

Assessed the impact of the

Performance patterns after EHR

transition to EHR use on quality

adoption varied by measure.

of healthcare.
(Lee et al., 2013)

Assessed the impact of basic

The results showed small but

EMR on healthcare quality

statistically significant association

outcomes.

of EMR adoption with healthcare
outcomes.
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(Romano &
Stafford, 2011)

(DesRoches et al.,
2010)

Examined the impact of EHRs

Findings indicated no significant

on outpatient care in the United

relationship between EHR with

States.

better quality.

Examined electronic health

No evidence of significant

record adoption in U.S.

differences in risk-adjusted length of

hospitals and the relationship to

stay, thirty-day readmission rates,

quality and efficiency.

and total hospital costs for hospitals
that have implemented EHR
systems and those without EHRs.

(Parente &
McCullough, 2009)

Conducted panel data to assess

EMR was associated with low level

the impact of EMR, nurse

of infection from medical care.

charts, and PACS on patient
safety outcomes.
(Linder et al., 2007)

Cross-sectional study to assess

No significant difference in

the association between EHR

performance between visits with and

implementation and quality of

without EHR.

ambulatory care.
(O’Connor et al.,
2005)

Examined the impact of EMR

Improvements in HbA1c and LDL

on diabetes quality of care using

levels frequency with EMR practice

panel data.

compared with non-EMR practice.
But there were no statistically
significant difference between both
practices at two or four years.

(Adams et al., 2003)

Evaluated the quality of

The use of the EMR was associated

pediatric primary care before

with improved quality of care.

and after the introduction of
EMR.
CDSS, CPOE and Healthcare Quality
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(Jones et al., 2014)

Systematic review of 147

1) CDS reported positive or

studies on the 170 key quality-

mixed-positive results with

related outcomes between 1995

respect to the improvements

and 2013.

in the processes targeted by
decision support,
2) CPOE reported positive or
mixed-positive effects with
respect to medication error
reduction.
3) A small proportion of studies
reported neutral or negative
results due to a particular
intervention, context, or
implementation.

(Radley et al., 2013)

Systematic review on CPOE

The use of CPOE decreased the

implementation in order to

likelihood of a prescription drug

estimate medication errors

order error by 48 percent.

reduction in hospitals that
adopted CPOE.
(Jaspers et al., 2011)

Conducted a systematic review

A significant impact on patient

on the effect of CDS systems on

outcomes and practitioner

patient outcomes and

performance.

practitioner performance.
(Chaudhry et al.,
2006)

Systematic review of 257

Well-implemented decision support

published studies on the impact

systems can yield real benefits.

of Health IT on healthcare
outcomes between 1995 and
2005.
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(Kaushal, Shojania,
& Bates, 2003)

Systematic review of CDS and

1) Some studies showed that

CPOE implementation on

the use of CDS and CPOE

medication safety.

improve adverse drug events
and medication errors.
2) Other studies reported
statistically insignificant
results.

Other studies as shown in Table 2 focused on broad range of health IT capabilities. For
example, Bardhan and Thouin (2013) conducted a three-year longitudinal study (2004 to 2006) of
a large panel of U.S. hospitals to assess the impact of four health IT applications (clinical
information systems, financial systems, scheduling systems, and human resource systems) on
healthcare process-centric quality metrics, and include treatment of acute myocardial infraction,
heart failure, pneumonia, and surgical infection prevention. The results indicated significant
difference in the usage of health IT systems and their impact on healthcare processes quality. Setia
et al. (2011) examined the impact of the assimilation and use of two health IT applications (clinical
and business applications) on hospital performance. The results showed that the effect varies
differently across the business and clinical process domains.
We observe that there is a lack of research on the influence of specific health IT combination
on healthcare outcomes. In particular, to our knowledge no paper examines the influence of the
synergy among EMR capabilities on healthcare outcomes. Our goal, in contrast, is to examine how
the synergy among EMR capabilities portfolio impacts healthcare quality. Pinaire and Sarnikar
(2015) recently published a paper that examines the synergy between health IT portfolios using
cross sectional data. However, this study has data limitation and did not specifically address EMR
capabilities portfolio. Our research, in contrast, focuses on the relationship between the synergy
among EMR capabilities and healthcare outcomes using longitudinal data for five-year period
from 2008 to 2012 inclusive.

13
Table 2. Health IT Portfolios
Study

Description

(Bardhan & Thouin, Used panel data to assess
2013)
four health IT applications

Results
The results indicated significant
difference in the impacts of health IT

impact on healthcare process- systems on healthcare processes
centric quality metrics.
(Pinaire & Sarnikar,
2015)

quality.

Assessed the impact of health Reported significant association
IT portfolios on the quality of between health IT portfolios
patient care.

synergistic impact and the quality of
patient care.

(Setia et al., 2011)

Examined the impacts of the

The effect of assimilation varies

assimilation and use of IT on

differently across the business and

the financial performance of

clinical process domains.

hospitals.
(Spaulding et al.,
2013)

Evaluated the comparative

Following the organizational model

importance of operational

of adoption is associated with

and organizational influences

increase in net income per patient

for complementary IT

day; whereas the operational model

systems. Examined the

of adoption is associated with

relationship between the

decrease in net income per patient

paths to IT adoption and

day.

financial performance.

Further, Cooper and Zmud (1990) argued that the mere adoption of IT may not be enough.
According to some economic studies (Brynjolfsson, 2005), innovation in IT may be insufficient,
and thousands of IT projects have failed to deliver on their productivity promise each year.
Complementarities in IT investments and organizational and managerial practices, however, are
the keys to the effective use of information technology in improving productivity and transforming
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an organization (Brynjolfsson, 2005). These IT-related practices create the synergies associated
with growth in productivity.
In the context of healthcare, health IT adoption alone without consideration of the
complementarities may substantially reduce the likelihood of benefiting from the investment in
health information technology (Briggs, 2014). Therefore, we posit that the synergy between health
ITs is important, and perhaps critically important to produce significant improvement in quality.
Further, earlier studies on assimilation and use have focused on the association between IT
assimilation and performance (Angst & Agarwal, 2009; Devaraj & Kohli, 2003; Pavlou & Sawy,
2006; Setia et al., 2011). There is however a lack of research assessing the association between
EMR capabilities assimilation and use and the quality of healthcare. This research addresses this
gap by examining how the synergy between EMR capabilities and EMR capabilities’ assimilation
impact healthcare quality outcomes over time.

2.2 Early Health IT Adoption
Because the extensive use of information technology is relatively new in many healthcare
settings, it is useful to review several studies in different disciplines that have tried to discover the
relationship between technology investment and business value (Angst et al., 2011). In many
industries, the use of information technology has been found to provide an opportunity to improve
quality, increase value to customers, and reduce cost. As mentioned above, it has been claimed
that early investment in information technology allows firms to improve their competitive position
and perhaps even outperform their competitors (Clemons & Row, 1988; Copeland & McKenney,
1988). Basically, the main focus of this study is on the timing of the adoption event (Fichman,
2000). Adoption is defined as acquiring or purchasing a new invention or innovation (Fichman &
Kemerer, 1999). Under this view, organizations that are early adopters are considered more
innovative than later adopters or not at all (Fichman, 2000). Firms may reap different values from
each new IT innovation. A new technology investment may provide an opportunity to gain
competitive advantage in terms of cost reduction and productivity enhancement. However, this
greatly depends on the new capabilities provided by the technology, and on firm and industry
characteristics (Dos Santos & Peffers, 1993).
In the healthcare industry, quantification of the extent to which information technology
adoption has improved quality or reduced cost is a difficult problem (Angst et al., 2011). A recent
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study conducted by Harvard Business Review/Verizon showed, “Only 27 percent of healthcare
organizations proactively seek to get first-mover advantage, compared with 36 percent that buy
new technology after others have proven its benefits and 35 percent that wait until something has
become well established” (Diana, 2014). The general consensus is that health IT adoption rate is
relatively slow in the U.S (Agarwal, Gao, DesRoches, & Jha, 2010). In general, the main
determinants of new technology adoption are the cost and the benefits of adoption (Hall & Khan,
2003). The benefits received by the users are the difference in future expected profits when a firm
switches to a newer technology.
Several studies investigated the factors influencing EMR adoption (Ash & Bates, 2005;
Menachemi, Mazurenko, Kazley, Diana, & Ford, 2012; Nambisan, Kreps, & Polit, 2013). In
particular, several factors are identified as major barriers to health IT adoption (Agarwal et al.,
2010). Financial factors are often considered as the primary obstacle for health IT adoption.
Hospitals are also concerned with the functionality and ease of use of health IT systems. This
factor could have adverse effects on user acceptance and use of the technology. Regulations also
play an important role in how hospitals adopt health IT solutions. Recently, the American
Recovery and Reinvestment Act of 2009 (ARRA), encourages hospitals and physicians to increase
the adoption of EHRs through monetary incentives. The goal is not adoption alone, but meaningful
use of EHR. Therefore, if the provider does not become a meaningful user of EHR in 2015,
penalties will be triggered through reduced Medicare reimbursement payments (ARRA, 2009).
However, there is limited research on the impact of EMR adoption timing on healthcare
quality. Basically, there is limited empirical evidence that early adoption of health IT can provide
health organizations with competitive advantages. Therefore, in the absence of strong evidence
that early adoption provide value for the firm, decision makers would doubt that IT investments
provide any real competitive advantage (Bittlestone, 1990). It is important to provide such
evidence since the costs of new technology tend to be high and the benefits are difficult to
determine in advance. According to Dos Santos and Peffers (1993), followers can implement IT
applications at lower cost since the cost of IT adoption tends to decrease over time. Therefore, the
benefits of early investment must be worthwhile for firms to take the lead in investing in a new IT
application.
In this research, we present the results of a study of the effects of early hospital investments
in advanced EMR capabilities, specifically CPOE and physician documentation. We attempt to
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answer this question: Did hospitals that were early adopters of advanced EMR capabilities gain
significant benefits in terms of healthcare quality?
2.3 The Sequence of Health IT Implementation
Policy makers are giving considerable attention and resources to increase EMR capabilities
adoption in order to improve the quality of healthcare. As mentioned earlier, EMR is one of the
most important components of healthcare technology applications yet the adoption process is
complex and often occurs incrementally over time.
As meaningful use requires adoption of certain EMR capabilities, knowing the sequence of
adoption of EMR capabilities adoption may reveal how the incentive program will impact this
approach and the unintended consequences (Adler-Milstein, Everson, & Lee, 2014).
In this context, little previous empirical evidence has examined the sequence of adoption of
EMR capabilities. Although some industry models such as the seven-stage HIMSS EMR adoption
model (EMRAM)3 identify the sequence of EMR capabilities adoption, no previous study of which
we are aware assesses the effects of the sequence of adoption on patient care and hospital
performance. There is also a literature that examines questions related to sequencing. One study
explored the relationship between technologies integration and hospital performance in terms of
cost and quality. The findings showed that the adoption patterns did impact the cost and quality
within the hospitals (Angst et al., 2011). Another study investigated the operational and
organizational factors as the key of explaining the difference in health technology adoption
patterns in healthcare settings (Spaulding et al., 2013). The findings from this study indicated that
the adoption pattern does matter and following organizational model of adoption increases the net
income per patient day.
Our goal, in contrast, is to identify the optimal sequence of EMR capabilities using panel data
and examine the impact of EMR capabilities ordering adoption on patient quality of care. The
seven-stage HIMSS EMRAM is a popular industry model that depicts different stages of adoption.
It helps healthcare organizations to analyze their EMR adoption level. In each stage, a set of
capabilities must be reached before moving to the next stage. In other words, EMRAM defines the
standard sequence of EMR adoption. In EMRAM model, Stage 1 includes automation of
3

Health Information Management and Systems Society. Electronic Medical Record
Adoption Model (EMRAM). 2014. http://www.himssanalytics.org/emram/emram.

17
laboratory, pharmacy and radiology ancillaries. In Stage 2, all the results should be delivered
electronically and linked to clinical data repository (CDR) that provides physician the access for
retrieving and reviewing results. In Stage 3, the first level of clinical decision support is
implemented to conduct error checking with order entry. In Stage 4, CPOE, for use by any
clinicians, added to nursing and CDR environment. The second-level of clinical decision support
related to evidence-based medicine protocols also exists in Stage 4. Stage 5 includes closed-loop
medication administration. At this stage, it is expected to see reduction in errors and alerts
associated with wrong medications. Physician documentation fits in Stage 6 of the EMR adoption
model. Physicians, at this stage, interact with patients and input their documentation close to the
point of care. Stage 7is full EMR implementation and fully paperless environment. Therefore,
organizations have the potential for electronic health information exchange, and electronically and
seamlessly share data with other organizations outside the enterprise.
Adler-Milstein, Everson, & Lee (2014) empirically assessed the sequence for EMR adoption
in hospitals using cross-sectional national data and their findings are largely consistent with
EMRAM. The results showed that decision support functions tended to be implemented in the
early to middle part of the sequence, but CPOE functions were implemented, on average, later in
the adoption sequence.
However, most (but not all) CPOE implementations have order communication (First
Consulting Group, 2003) and thus include several manual and/or paper-based work systems that
are prone to errors (Baron & Dighe, 2011). Order communication functionality allows CPOE
system to automatically transmit provider orders and avoid several potentially inefficient and
error-based steps. However, according to 2012 annual report of the U.S. hospital IT market, the
new generation of CPOE applications continue to replace legacy order entry application as they
can accommodate patient orders from all clinicians supported by clinical decision support
(HIMSS, 2012).
We also investigated the logical dependency among certain EMR capabilities. Major ancillary
clinical systems feed orders and results data to CDR which consists of a real time database that
stores patient electronic records, including patient demographics, electronic reports and results
from lab, imaging, and other diagnostic services (HIMSS, 2013). Physicians or any clinicians can
enter orders directly into CPOE. At this point, CDR permits CPOE to display relevant clinical
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information and provide clinical decision support during the order entry process (Baron & Dighe,
2011). CDR includes CDSS for conflict checking such as duplicate orders (HIMSS, 2013).
Therefore, it is obvious that CDR, order entry to feed orders, and some functionalities of CDSS
precede CPOE implementations. Physician documentation, on the other hand, is concerned with
the use of structured template and point-and–click capabilities. It helps physicians transit from
written to electronic notes. As with CPOE, physician documentation systems are complex systems
and included in the latter stages of EMR adoption (Dranove, Forman, Goldfarb, & Greenstein,
2012).
Based on EMRAM, the general trend is to implement EMR capabilities such as CDR, order
entry, CDSS in the first stages and add more advanced EMR capabilities such as CPOE and
physician documentation later in the sequence. Since EMRAM identifies the standard sequence,
and (Adler-Milstein et al., 2014) study tracked hospital EMR adoption using cross sectional data,
in this study, we will track EMR capabilities adoption sequence using longitudinal data and
examine the impact of the sequence of EMR capabilities on healthcare quality.
In this study, we used seven quality measures from the hospital compare database. These
include heart attack mortality, heart attack readmission, heart failure mortality, heart failure
readmission, pneumonia mortality, pneumonia readmission. These quality measures capture the
degree to which hospitals provide the recommended treatments for specific types of health
conditions. We also examine patient experience using a patient satisfaction measure. A more
detailed description of these quality measures is reported in Appendix A and B.
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CHAPTER 3
RESEARCH MODEL
3.1 Research Objectives
There are three main research objectives in this dissertation. First, examining the impact of
the complementarities among EMR capabilities and the implementation of different EMR
capabilities on the quality of healthcare. Second, investigating the effects of adoption timing
associated with EMR capabilities on healthcare quality. Third, exploring the impact of the
sequence of EMR capabilities adoption on healthcare quality.
Overall, this research answers three questions related to EMR: What to adopt? When to adopt?
And in what sequence?
3.1.1 Research Objective 1

Examining the synergistic impact of electronic medical records (EMR) capabilities, and the effects
of assimilation and use on the healthcare quality performance of hospitals.
Objective 1.a: Explore the relationship between the synergy among different EMR capabilities and

their impact on the quality of healthcare delivery over time using large cross-section of hospitals
over a multi-year period.
In addressing the above research objective, we focus on the portfolio of EMR capabilities and
the complementarities, or synergy between the capabilities in a given EMR portfolio and its impact
the quality of healthcare. The IT portfolio of an organization is defined as “its total investment in
computing and communication technology” (Weill & Vitale, 2002). In a healthcare context, our
view is that, when a hospital moves from a level of individual EMR capability investment for its
work processes to a portfolio level, the synergies between the portfolio components can lead to
greater benefits, i.e., increased quality of patient care. Cho and Shaw (2009) argued that greater
potential synergy enhancement between IT investment units may enable an organization to earn
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additional value from its investment. This research views the synergy between EMR capabilities
portfolio as a potential source for a healthcare facility to achieve improvements in the quality of
healthcare. This study tracks the synergy between different EMR capabilities and their impact on
quality of care using hospital panel data over the period from 2008 to 2012. The measure of quality
improvement, QI, can be represented as:
𝑄𝐼 = 𝑄𝐼(𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑 𝑖𝑚𝑝𝑟𝑜𝑣𝑒𝑚𝑒𝑛𝑡𝑠 𝑜𝑓 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙 𝐸𝑀𝑅 𝑐𝑎𝑝𝑎𝑏𝑖𝑙𝑖𝑡𝑖𝑒𝑠, 𝑠𝑦𝑛𝑒𝑟𝑔𝑦)
The concept of synergy has been discussed in strategy and economic literatures and is defined
as the additional value the organization can achieve from multiple investment units which cannot
be attained from stand-alone individual units (Tanriverdi, 2005, 2006). Basically, two types of
synergies were discussed; sub-additive cost and super-additive value. Business units that use
common resources such as IT infrastructure technologies and IT management practices
(relatedness) lead to sub-additive cost while complementarities between the two is the major
source of super-additive value synergy. Complementarities here refers to the relationship between
inputs, and the enhancement of one resource’s value in the presence of another resource (Milgrom
& Roberts, 1990, 1995).
The term complementarity was first introduced in economic to illustrate the idea that the
increase in one variable level will increase the return of increasing its complementary variables
(Barua, Sophie Lee, & Whinston, 1996). Complementary assets or resources are more valuable
when used together than when used in isolation (Brynjolfsson, Hitt, & Yang, 1998). IT
organizational characteristics and processes are complementary factors and they cannot succeed if
done separately (Barua et al., 1996). Although resources are distinct, they are interdependent and
mutually support each other (Tanriverdi, 2006), and the presence of the interaction among these
resources is the factor that explains variance in the return from a given IT resource (Ray, Muhanna,
& Barney, 2005).
Cho and Shaw (2013) have argued that IT resources have a greater potential for synergy
enhancement than non-IT resources. The unique characteristics of IT resources justify this
argument. Basically, IT resources are more sharable than non-IT resources. Different business
investment units can share business processes and exchange data. Therefore, the unique
characteristics of IT enhance the complementarities between IT systems and the data provided by
one IT system makes other systems more valuable. In this study, synergy refers to the additional
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expected quality return that can be achieved from multiple health IT investments (EMR
capabilities) which cannot be obtained from stand-alone individual technology.

Objective 1.b: Exploring the relationship between different EMR capabilities’ assimilation and

use and their impact on the quality of healthcare delivery over time.

A number of research studies argue that IT assimilation and use have an important role in
enhancing organizational performance (Devaraj & Kohli, 2003; Setia et al., 2011). IT assimilation
and use can be classified into two categories; IT exploration and IT exploitation. IT exploration
refers to the “number of technological solutions adopted and used by the organization”, while IT
exploitation is the “average years of experience with these solutions” (Setia et al., 2011). In
organizational studies, exploration’s returns are often uncertain, while exploitation’s returns are
more predictable (Chen & Katila, 2008). In this context, the benefits from exploration are
uncertain, unless it is subsequently followed by an extended period of exploitation (Setia et al.,
2011). Zima (2002) argued that a large number of technologies are not enough to achieve efficient
performance without the hospital’s ability to develop extensive experience with these
technologies. This research focuses on examining how the complementarities between the
exploration and exploitation of a different EMR capabilities impact the quality of healthcare.
Complementarities here refer to the enhancement of one resource’s value in the presence of another
resource (Milgrom & Roberts, 1995).
We expect that hospitals will realize greater benefits in terms of quality of healthcare
outcomes from a given EMR capabilities portfolio if they are combined with higher levels of
assimilation and use. According to Devaraj and Kohli (2003), higher levels of use enhance the
performance impacts of information technologies. Higher technologies exploration captures the
hospital’s efforts to explore more information technologies for digitizing its work processes. While
higher technologies exploitation measures the length of time for which the information
technologies have been used (Setia et al., 2011).
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3.1.2 Research Objective 2

Understand how hospitals’ early adoption of EMR capabilities effects various healthcare quality
measures.
The goal is to explore the effect of adoption timing of EMR capabilities portfolio on healthcare
quality. The concepts of adoption can be defined broadly as moving from not having to having the
technology. In a healthcare context, adoption of health IT starts with a contract to purchase a health
IT, installation, and then integration of the health system/s into the work processes. In other words,
adoption usually consists of acquiring, implementing, and using the system within the work
processes. The assumption behind adoption is that the investment in technology will lead to better
quality, efficiency, and lower-cost processes. As mentioned in the introduction, to ensure
successful technology initiatives, project management should be used to plan, develop, test, and
deploy technologies across all organizational units. The literature distinguishes between two types
of adopters: early adopters versus late adopters. Early adopters who are interested in a technology
and willing to take risks. They learn through their own trial-and-error process and may find the
proper combination of EMR capabilities that applies best to their situation.
Further, the health information technology report shows adoption statistics of EMR systems
in non-federal acute care hospitals from 2008 to 2013, hospital adoption of EMR systems increased
from 9.4 percent to 59.4 percent. In 2008, only 1.6 percent of hospitals adopted comprehensive
EMR functionalities and the majority adopted basic EMR functionalities (Charles, Gabriel, &
Furukawa, 2014). The basic EMR system includes order entry, CDR, CDSS capabilities (Dranove
et al., 2012). In 2008, another national survey shows about 42 percent of office-based physicians
used any EMR systems and only 16.9 percent of physicians who reported having systems meeting
the criteria for a basic EMR system (Hsiao, Hing, Socey, & Cai, 2011). Based on HIMSS analytics
database, CDR, CDSS, and order entry are older technologies and the adoption rate for each of
these technologies is about 85 percent in 2008. While the adoption rate for the advanced EMR
capabilities (CPOE and physician documentation) is very low. According to American Hospital
Association and the Federation of American Hospitals survey, less than 5 percent of American
hospitals adopted CPOE in 2002 and less than 22 percent in 2008, while less than 21 percent
adopted physician documentation by 2008 (Dranove et al., 2012). Therefore, in this study, we only
focus on examining the effects of early adoption of advanced EMR capabilities.
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To determine the effects of early investment in CPOE and physician documentation, we
gathered data on these applications adoption and patient quality measures. As shown in HIMSS
analytics database, CPOE emerges at the end of 2002 and at the beginning of 2003. While
physician documentation emerges in 2005. In this study, we are interested in determining whether
hospitals that invested in CPOE and physician documentation in the early adoption period were
able to improve patient quality. We determined the early adoption period for CPOE and physician
documentation as follows:
-

CPOE early period data used in this study is from 2003-2008. During this period, the
hospitals adopted CPOE may have been able to appropriate much of the value to be gained
from early adoption of this technology (Dos Santos & Peffers, 1993; Lieberman &
Montgomery, 1988).

-

HIMSS analytics database first introduced physician documentation in 2005. Therefore,
the adoption data for physician documentation covers the period 2005-2008.

Since the adoption rate is low for both technologies, it is unlikely that any effects of adoption
would be observed immediately after implementation. In the sample data, about 22 percent of the
hospitals adopted CPOE by 2008 and less than 21 percent adopted physician documentation by
2008. Hence gains in quality improvements resulting from CPOE and physician documentation
may be observed after 2008 for CPOE and physician documentation. Therefore, patient quality
measures data for 2009 will be used to measure patient quality after the early adoption period of
CPOE and physician documentation.
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3.1.3 Research Objective 3

Explore the effects of the sequence of EMR capabilities implementation on various healthcare
quality measures.
In this research, we aim at investigating the impact of EMR capabilities’ sequence of adoption
on healthcare quality. HIMSS analytics database specifies the stages of EMR adoption. It starts
with basic EMR (CDR, CDSS, or order entry) and then moves to advanced EMR (CPOE, or
physician documentation). In this study, we will explore the current EMR adoption sequences and
then compare these sequences to the EMR reference sequence and then examine the performance
effects related to the sequence of EMR adoption. The question is whether the order of adoption
impacts various healthcare quality measures.
Our approach to define the reference EMR capabilities adoption sequence is as follows:

Figure 1: EMR Reference Sequence
o Track EMR capabilities sequence adoption longitudinally from 2005-2012.
o Identify EMR sequence capabilities adoption from the full dataset.
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o Evaluate the sequences of EMR capabilities adoption based on hospital quality rate.
If the hospital quality rate greater than national rate, then the sequence corresponds
to that hospital is considered as a reference sequence. In order to identify hospital
performance, we use “mortality and readmission rates comparison to the national
level” data. In particular, if the hospital’s “Mortality Rate” and “Readmission Rate”
is better than (i.e. less than) the average national rate, then the EMR capabilities
sequence corresponds to that hospital is considered as a reference sequence in this
study.


This step may result in more than one EMR reference sequences.

o Because of the existence of multiple EMR adoption reference sequences, we will
calculate the Levenshtein distance for each hospital’s EMR capabilities adoption
sequence against all the reference sequences. The smallest distance obtained from
the comparisons to the reference sequences will be used as EMR sequence distance
(Spaulding et al., 2013).
Further, we note the hospital that adopted more than one EMR capability in a single year will
be dropped from the sample set because it is not possible to distinguish which application was
adopted first especially if the data on “Month” variable is missing.
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CHAPTER 4
RESEARCH METHODOLOGY

4.1 Model Specifications
4.1.1 Research Objective 1: Model Specification

We estimated the following two regression models using fixed effects, and with various
quality measures as the dependent variable.
The following regression model tests the relationship between the synergy among different
EMR capabilities and their impact on the quality of healthcare delivery over time. In line with
HIMSS analytics database classification of EMR capabilities, our analysis focuses on portfolios
of different combinations of EMR capabilities as specified in equation (1):
(1) Yi, t = a0 + α1CDRi, t + α2CDSSi, t + α3OEi, t + α4PDi, t + α5CPOEi, t +
α6SYN(CDR, CDSS, OE)i, t + a7SYN (CDR, CDSS, OE, PD, CPOE)i, t + α8hosp_sizei, t +
α9CMIi, t + α10hosp_owneri, t + α11academic_hospi, t + α12hosp_agei, t + εi, t
Where 𝑌i, t represents the quality measure results in hospital i in year t. (α1CDRi, t +
α2CDSSi, t + α3OEi, t + α4PDi, t + α5CPOEi, t) represent individual EMR capabilities in
hospital i in year t. The coefficients of these capabilities capture the effect of individual EMR
capabilities

on

healthcare

quality

when

the

synergy

effects

are

not

present.

(α6SYN(CDR, CDSS, OE)i, t ) represents the synergies (interaction) between EMR capabilities in
the basic EMR portfolio in hospital i in year t. (α7SYN(CDR, CDSS, OE, PD, CPOE)i, t ) represents
the synergies (interaction) between EMR capabilities in the full EMR portfolio in hospital i in year
t.(α8hosp_sizei, t + α9CMIi, t + α10hosp_owneri, t + α11academic_hospi, t +
α12hosp_agei, t) represent the control variables in hospital i in year t. 𝜀i, t represents the error
term for hospital i in year t.
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We focused on five health IT systems described in the HIMSS data: CDR, CPOE, CDSS,
Order Entry (OE), and Physician Documentation (PD). These capabilities constitute EMR
portfolios. Building on HIMSS report on EMR categorizations (Charles et al., 2014), we identify
two portfolios of EMR capabilities: Basic EMR portfolio and full (comprehensive) EMR portfolio.
Basic EMR capabilities portfolio includes two levels: basic EMR portfolio and includes three EMR
capabilities-CDR, CDSS, and OE; and basic EMR capabilities with PD and include four EMR
capabilities- CDR, CDSS, OE, and PD. The full EMR capabilities portfolio also has two levels:
full EMR capabilities with PD and includes all five EMR capabilities, and full EMR capabilities
with no PD. In our regression model, we only focused on the basic EMR (with no PD) and the full
EMR (with PD) portfolios. (See section 4.1.1.2 for more details.)
Hospitals that adopt full EMR portfolio have more thorough implementation of EMR systems.
Figure 2 presents the average adoption levels of EMR capabilities and EMR portfolios from 20082012. The adoption rate of basic EMR is 58 percent while only 22 percent of hospitals adopted
basic EMR with PD. One the other hand, the adoption rate of full EMR capabilities portfolio is 23
percent and only 14 percent of hospitals adopt full EMR capabilities with PD portfolio. The
numbers reflect only live and operational capabilities. In our study, the synergy between EMR
capabilities in a portfolio is measured as the product (interaction) of EMR systems. For example,
if the hospital has adopted CDR, CDSS, and OE in the basic EMR portfolio and all of them are
live and operational then the value taken by the synergy variable is one, otherwise zero. This
measure indicates that hospitals that achieve a score of one have a more thorough implementation
of EMR systems.
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Figure 2. Average Adoption Level of EMR Capabilities (2008-2012)
Model 2 estimates the relationship between different EMR capabilities’ assimilation and use
and to determine their impact on quality of healthcare delivery over time:
(2) Quality measure i, t
= α0 + α1EMRExploration i, t + a2EMRExploitation i, t
+ α3InteractionEE i, t + α4hsop_size i, t + α5CMI i, t + α6hosp_owner i, t
+ α6academic_hosp i, t + α7hosp_age i, t + 𝜀i, t
Where quality measure represents the quality measure results in hospital i in year t.
[α1EMRExploration i,t] represents the extent of health IT applications adoption in the EMR
portfolio in hospital i in year t, [a2EMRExploitation i,t] represents the average years of experience
with EMR portfolio in hospital i in year t, [α3InteractionEE i,t] represents the interaction (product)
of EMR exploration and exploitation in hospital i in year t, [α4hosp_size i,t + α5CMI i,t +
α6hosp_owner i,t + α6academic_hosp i,t + α7hosp_age i,t] represent the control variables Hospital
Size, CMI, Hospital Ownership, Academic Hospitals, and Hospital Age respectively in hospital i
in year t. 𝜀i, t represents the error term for hospital i in year t.
In this model, the coefficient of interest is α3 which estimates the quality improvement from
the assimilation and use of EMR capabilities.
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Our data set contains large number of hospitals observed over five time periods. We estimate
a panel regression model for each quality measure using unbalanced panel (at least two years of
data), and then using a balanced panel (all five years of data). The statistical analysis was
conducted using Base SAS 9.4. Our initial analysis on the full panel data indicated both
heteroscedasticity and autocorrelation. More specifically, we conduct Breusch-Pagan test to check
for heteroscedasticity (Breusch & Pagan, 1980). The results indicate the presence of
heteroscedasticity. In particular, the p-value is less than 0.05. Therefore, we reject the null
hypothesis of homoscedasticity. We also conducted a Pesaran (2004) CD test to check for
autocorrelation. The results confirm the existence of significant autocorrelation in our panel data
based on the p-value (p < 0.05). Autocorrelation is common in panel data (Certo & Semadeni,
2006). We correct for these issues by using heteroscedasticity and the autocorrelation consistent
(HAC) standard errors. This known as Newey-West standard errors (Newey & West, 1994). We
also check for multi-collinearity in our models and found that variance inflation factors were below
the acceptable threshold (less than 10) as shown in Table 3 (Kennedy, 2003). In addition to VIF
results, we conduct a Spearman correlation test because our independent variables in the first subobjective (Synergy between EMR capabilities) are binary variables. The threshold point is less
than 0.5 and indicates no significant multicollinearity problem exist (Oh, Agrawal, & Rao, 2013),
and less than 0.7 indicates no serious multicollinearity problem exist (Tabachnick & Fidell, 2001).
The results of Spearman’s rank correlation (as shown in Appendix E) show that there are
some correlation between the individual variables and EMR portfolios and correlation between
EMR portfolios as well. According to Tabachnick and Fidell (2001), it is recommended to omit
one of the variables from the model to handle multicollinearity problem. Therefore, we evaluated
our model by including only one variable and then measured the effect of placing correlated
variables in the same model (Muir, Berg, Chesworth, Klar, & Speechley, 2010). As a result, we
decided to omit basic EMR-PD and full EMR-No PD portfolios from our model4. The results of
Spearman correlation test show that no serious multicollinearity problem exists between the
remaining independent variables.

4

We tested the model with all four portfolios and results patterns are similar (See Appendix F).
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Further, the Hausman test is regularly deployed as a test to examine whether fixed effects can
be used, or whether random effects should be used instead (Hausman, 1978). The null hypothesis
indicates that the random effects model is the appropriate model while the alternative hypothesis
states that the fixed effects model is the appropriate model. In this study, the p-value in Hausman
test is less than 0.05 and hence we rejected the null hypothesis. In this study, the fixed effects is
the appropriate model.
Table 3. Variance Inflation Factors in Panel Data across Health Conditions
Variables/Quality HAM

HAR

HFM

HFR

PNM

PNR

PS

Measures
First Sub-Objective (Synergy Between EMR Capabilities) Variables
OE

1.38

2.89

1.37

1.14

1.39

1.43

1.39

CDSS

3.63

2.80

3.62

3.62

3.56

3.57

3.75

CDR

1.87

1.51

1.89

1.87

1.88

1.86

2.04

CPOE

3.87

2.72

3.59

3.94

3.59

3.95

3.90

PD

4.60

3.32

4.61

4.80

4.64

4.81

5.00

Basic EMR

6.55

6.59

6.57

6.62

6.47

6.55

7.70

Basic EMR-PD

6.50

6.07

6.50

6.81

6.53

6.83

8.75

Full EMR

3.87

4.80

5.34

4.01

3.82

4.02

6.67

Full EMR-No PD 5.42

4.89

5.34

5.79

5.35

5.80

7.54

Hospital size

2.02

1.88

2.15

2.17

2.15

2.16

1.76

Hospital age

1.21

1.22

1.21

1.21

1.21

1.21

1.19

For-Profit

1.28

1.26

1.28

1.29

1.28

1.29

1.12

Academic

1.18

1.18

1.17

1.15

1.16

1.15

1.14

4.76

4.85

4.95

Second Sub-Objective (Assimilation and Use) Variables
EMR Exploration 4.66

4.90

4.81

4.87
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EMR

5.97

5.77

5.96

6.12

5.95

6.13

6.92

8.05

7.65

8.24

8.10

8.21

8.08

7.37

Exploitation
EMR
Assimilation and
Use

The first objective of this study is to estimate the impact of different implementations of EMR
capabilities and their assimilation and use on healthcare quality using panel data model design. In
this design, however, there is a large possibility of confounding variables biasing the effect of the
portfolio of EMR capabilities and EMR capabilities assimilation and use. One possible solution to
handle this issue is to use control variables in order to identify these confounding variables and
include them in the regression models. However, the likelihood of ruling out all possible
confounding variables is very small, and as a result leads to omitted variable bias.
In this research, we used a fixed effects model which exploits the within-hospital effect of
EMR capabilities implementation across time. The strength of the fixed effects model is the ability
to control for confounding variables (Furukawa, Raghu, & Shao, 2010a). Therefore, the use of
fixed effects modeling allows for a partial solution to the omitted variable bias issue (Wooldridge,
2010). Another important benefit of fixed effects, this technique controls for all observed and
unobserved time-invariant characteristics of the hospitals. Consequently, this technique removes
potential sources of bias from the estimates by controlling for all time-invariant hospital
characteristics, whether they are observed or not. However, health IT adoption might affect our
results. For instance, high quality hospitals may be more prevalent in health IT adoption and this
would cause cross-sectional regressions to overestimate the effect of health IT on quality. Low
quality hospitals, on the other hand, might adopt health IT to improve their performance and this
would cause the cross-regressions to underestimate the effect of health IT on quality (McCullough,
Casey, Moscovice, & Prasad, 2010). To address this issue, we include both hospital and time fixed
effects in our regression models. In this case, fixed effects include a separate indicator variable for
each hospital and each year in the regression. Although this approach improves the analysis, we
discuss some potential limitations in Chapter 6.
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All regression models in this study include control variables for hospital size, hospital
ownership, case mix index, teaching status, and hospital age. Finally, to test the robustness of our
results, we analyze the panel data on large hospitals (at least 100 beds) that are most likely to have
a thorough implementation of EMR capabilities (Appari, Eric Johnson, & Anthony, 2013). The
pattern of the results did not change. (Results are reported in Appendix C.)

4.1.2 Objective 2: Model Specification

In order to determine whether early investors in CPOE and physician documentation were
able to gain more improvement on quality, we formulated the following regression models to
separately measure the effects of CPOE and physician documentation early adoption:
(1) Quality measure
= α0 + α1CPOEAdopt + α2TechMaturity + α3hosp_size + α4CMI
+ α5hosp_owner + α6academic_hosp + α7hosp_age + ε
Where
CPOEAdopt

=

1 if a hospital has adopted CPOE before 2008

=

0 otherwise.

TechMaturity: a control variable measures the number of years the hospital has had CPOE.
[α3hosp_size + α4CMI + α5hosp_owner + α6academic_hosp + α7hosp_age] represents the
other control variables Hospital Size, CMI, and Hospital Ownership, Academic Hospital, and
Hospital Age respectively. 𝜀 represents the error term.
The key coefficient of interest is α1, which estimates the quality improvement from early adoption
of CPOE.
The model coefficients will be estimated for the year 2009. A summary of the results will be
obtained by ordinary least squares (OLS) estimation of the model.
The following regression model determines whether early investors in physician documentation
were able to gain more improvement on quality:
(2) Quality measure = α0+ α1PDAdopt + α2TechMaturity + α3hosp_size + α4CMI +

α5hosp_owner + α6academic_hosp + α7hosp_age+ 𝜀
Where
PDAdopt

=

1 if a hospital has adopted physician documentation before 2008
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=

0 otherwise.

TechMaturity: a control variable measures the number of years the hospital has had physician
documentation.
[α3hosp_size + α4CMI + α5hosp_owner + α6academic_hosp + α7hosp_age] represents the
other control variables Hospital Size, CMI, and Hospital Ownership Academic Hospital, and
Hospital Age respectively. 𝜀 represents the error term
The key coefficient of interest is α1, which estimates the quality improvement from early adoption
of physician documentation. The model coefficients will be estimated for the year 2009. A
summary of the results will be obtained by OLS estimation of the model.

We estimated the OLS using the REG procedure using SAS statistical software. We checked
for multi-collinearity in our model using variance inflation factors and the results are within the
acceptable threshold (less than 10) (Kennedy, 2003). We performed the White standard error
correction to correct for heteroscedasticity (White, 1980). The initial investigations revealed that
some control variables (NofBeds and Age) were not normally distributed. Therefore, we
performed a logarithmic transformation on these variables (Gelman & Hill, 2007).
Further, we included the following status during the early adoption period for both CPOE and
physician documentation applications: (contracted/not yet installed, installation in process, live
and operational, to be replaced). The reason for including (contracted/not yet installed) application
status because it is assumed that the implementation begins, on average, one year after the contract
date (Furukawa et al., 2010b).
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4.1.3 Research Objective 3: Model Specification

We estimated the following regression model using ordinary least squares regression, and with
quality measures results as the dependent variable.
The following regression model tests the relationship between the paths to EMR capabilities
adoption and its impact on the quality of healthcare delivery:
(1) Quality measure
= α0 + α1EMRSQDIS + α2hosp_size + α3CMI + α4hosp_owner
+ α5academic_hosp + α6hosp_age + ε
Where quality measure represents the quality measure results, EMRSQDIS captures the
distance between the observed EMR capabilities sequences and EMR capabilities reference
sequence (i.e. the smaller the distance the greater the similarity to the reference sequence),
[α3hosp_size + α4CMI + α5hosp_owner + α5academic_hosp + α6hosp_age] represents the control
variables Hospital Size, CMI, and Hospital Ownership, Academic Hospitals, and Hospital Age
respectively. 𝜀 represents the error term.
In order to conduct sequences comparison, it is required to use dynamic programming
methods to calculate the distance between pairs of sequences. For example, suppose we have the
following reference and observed EMR sequences followed by the hospitals in the dataset:
Reference sequence (A): CDR- OE -CDSS-CPOE-PD
Observed sequence (B): CDSS- CDR-OE -CPOE- PD
The algorithm for calculating the distance score is as follows:
IF two elements in sequence A and B at ith and jth position
are same THEN
The distance score is 0 (D(i,j)=0)
ELSE IF
ith and jth position are not the same THEN
Distance score is assumed as 1 (D(i,j)= 1)
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END IF



Distance score of zero means the hospital
followed the theorized sequence
The distance score different from zero (penalty
gap (δ)) can be user defined

The distance score between ith and jth is determined by:
1. a Match (ith, jth)  ith = jth
2. a Deletion (d)

 score (ith, jth) is based on the value of δ

3. an Addition (a)

 score (ith, jth) is based on the value of δ

The perfect sequence match between two sequences each with a length of five elements would
be 5; 1 credit for every matching between two elements in the sequence. In the above example,
sequence (A) is 5 elements and (B) is also 5. However, the observed sequence (B) does not
perfectly follow the reference one. For the first step, the Levenshtein distance will be used: A
measure from information technology that counts the number of operations needed to transform
one sequence to another (Brzinsky-Fay, Kohler, & Luniak, 2006). The penalty of each operation
is 1. This means that each operation increases the distance by 1. In our study context, the maximum
number of operations to transform any sequence is five.
Let C(x) = ∑ C(d), C(a), where C(x) is the total number of deletion and addition operations; C(d)
is the number of deletion operations; C(a) is the number of addition operations.
The overall distance between sequence A and B is equal:
S(A, B) = C (x) where δ(d)= δ(a)=1.
In the observed sequence, CDR should occur before CDSS and not after it. This can be corrected
with one deletion and one insertion.
The observed sequence after first transformation: CDR-> CDSS->OE-> CPOE-> PD
Further, order entry should occur before CDSS. This can be corrected with one deletion and one
insertion.
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The observed sequence after first transformation: CDR-> OE-> CDSS-> CPOE->PD
The total number of operation is 4 (two deletion and two insertion). Hence, the hospital would
receive a distance of 4.
We conduct the analysis using R software package and used the procedure (levenshteinDist)
to calculate the distance between the observed and reference sequences. After the data transformed
to short form, we analyze it with SAS software to estimate the impact of EMR capabilities
sequences on healthcare quality outcomes using OLS (REG procedure). We check for multicollinearity in our model using variance inflation factors and the results are within the acceptable
threshold (less than 10) (Kennedy, 2003). The initial investigations revealed that some control
variables (NofBeds and Age) were not normally distributed. Therefore, we perform a logarithmic
transformation on these variables (Gelman & Hill, 2007).

4.2 Data Sources
We now describe the data sources used in this study along with description of the variables
used in model development.
We collected the research data from three sources. First, we obtained data on hospital EMR
capabilities portfolio from HIMSS Analytics5. It represents the comprehensive set of different
categories of IT applications across a large cross-section of U.S. hospitals. For the purpose of this
study, we used panel data to conduct the analysis. According to Devaraj and Kohli (2003), a crosssectional set of hospitals combined with time-series data is ideal to examine the effect of IT
investment on measures of profitability and quality, while controlling for other factors. Therefore,
this study aims to conduct a more granular and comprehensive examination on the aforementioned
research questions using panel data.
Second, we obtained data on quality of patient care measures from the Medicare’s Hospital
Compare website6. The data obtained on quality outcome measures is for the same set of hospitals
on which EMR capabilities data was available through the HIMSS Analytics database.

5
6

Formerly The Dorenfest Integrated Healthcare Delivery System + (IHDS+) database
Hospital Compare. http://www.hospitalcompare.hhs.gov/.
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Third, we used Center for Medicare and Medicaid Services (CMS) to obtain data on one of
the control variables-Case Mix Index (CMI). The three data sources were combined using the
Medicare Number or Provider Number available at each source.

4.3 Quality Measures
In this research, several types of quality outcomes measures are considered. These include
heart attack mortality rates, heart attack readmission rates, heart failure mortality rates, heart
failure readmission rates, pneumonia mortality rates, pneumonia readmission rates. We obtained
these measures from Medicare’s Hospital Compare website. Basically, these quality measures
capture the degree to which hospitals provide the recommended treatments for specific types of
health conditions. Understanding the effect of health IT on the quality measures is essential, as
these explain the downstream differences in the overall patient outcomes, such as mortality rates
(Bardhan & Thouin, 2013).
We also examine a patient satisfaction measure. The Centers for Medicare and Medicaid
Services (CMS) developed a national, standardized survey instrument and data collection
methodology for measuring patients’ perception of their hospital experiences. The instrument is
called the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS)
survey. The survey captures patient experience on care and patient rating items that include nine
key dimensions: communication with doctors, communication with nurses, responsiveness of
hospital staff, pain management, communication about medicines, discharge information,
cleanliness of the hospital environment, quietness of the hospital environment, and transition of
care7. In our study, we considered the following question from the survey:

Would you recommend the hospital to friends and family? For this question, we focused on the
percentage of respondents who said they would definitely recommend the hospital.

Mortality, readmission, and patient satisfaction are often used as indicators of healthcare
quality (Amarasingham et al., 2009; DesRoches et al., 2010; Lee et al., 2013; McCullough et al.,
2010; Pinaire & Sarnikar, 2015; Piontek et al., 2010; Restuccia, Cohen, Horwitt, & Shwartz, 2012;
7

http://www.hcahpsonline.org/
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Vest & Miller, 2011). Basically, high quality health care provides the required clinical care
processes that are supposed to achieve the health outcomes desired by the patient (Nelson, Mohr,
Batalden, & Plume, 1996). Therefore, improving patient care outcomes is the primary goal of
hospital quality improvement. According to the Medicare’s Hospital Compare 8, health outcomes
are used as measures of health care quality. For instance, readmission indicators provide
information about the potential issues with a hospital’s systems. These include: “transiting patients
to the outpatient setting, collaborating with communities and providers, and communicating with
patients and caregivers”. Just as importantly, mortality measures provide information about the
potential issues with a hospital’s clinical quality. This information will inform hospitals and other
stakeholders (employers, payers such as insurance company, and health plans) about the key
aspects of quality of care; comprehensive assessment of patient outcomes as well as the value of
care for patients with these conditions. Therefore, patients who receive high level of care quality
during the hospital stays and transition to the outpatient setting will likely have better outcomes,
such as functional ability, survival, and quality of life. Although, in certain cases, the deaths may
not be the results of quality failure, the expectation is that there are many preventable death cases9.
In summary, outcomes indicators allow hospitals, policy makers, and other stakeholders to assess
the patient quality of care in order to seek improvements that will impact patient wellbeing.

McCullough, Casey, Moscovice, and Prasad (2010) investigated the relationship between
quality measures and health IT systems through consultations with physicians, nurses,
administrators, and health informatics practitioners and consultants. The results indicated that the
process quality measures “largely reflect the quality of hospitals’ medication administration
processes.” Consequently, health IT systems such as EMR and CPOE are designed to retrieve and
communicate information pertaining to medication prescribing and delivery. McCullough et al.
(2010), “clinical errors cause at least 44,000 deaths annually in the United States.” The main causes
of this high death rates come from “process errors or the failure to provide recommended
treatments for patients with certain medical conditions.” However, health IT systems have been
proven to hold the potential to improve the quality of healthcare. Basically, the health IT systems,
such as CPOE and CDSS, are designed to facilitate the implementation of care guidelines and

8
9

Hospital Compare. http://www.hospitalcompare.hhs.gov/
https://www.medicare.gov/
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decision support tools, which may be essential in preventing or reducing process errors (Hillestad
et al., 2005; McCullough et al., 2010; Radley et al., 2013).
We build on this literature by measuring the effect of the portfolio of EMR capabilities on
various quality measures and patient satisfaction. Our data follows hospitals over time, allowing
us to examine the change in the quality measures that followed the adoption of health IT systems
within individual hospitals.

4.4 Hospitals Characteristics
Consistent with past studies (Bardhan & Thouin, 2013; Devaraj & Kohli, 2003; Lee et al.,
2013; Setia et al., 2011), we included a set of control variables that may influence the impact of
EMR capabilities on quality measures. Specifically, we control for hospital size; hospital
ownership; hospital case mix index (CMI); teaching status; and hospital age.

4.5 Variables
Table 4 presents the study variables for each objectives. The dependent variables for all
objectives are the quality outcome measures results obtained from Medicare’s Hospital Compare
Database. The quality measures include heart attack mortality rates, heart attack readmission rates,
heart failure mortality rates, heart failure readmission rates, pneumonia mortality rates, pneumonia
readmission rates, and the level of patient satisfaction. Consistent with past studies, we include a
set of control variables that may influence the impact of EMR on hospital quality outcomes
measures. Specifically, we control for: Hospital size, which represents the number of hospital beds
and it is measured as the logarithm of the total number of hospital bed. Profit status, where forprofit hospitals are coded as one and not-for-profit hospitals are coded as zero. Hospital case mix
index (CMI) which accounts for the average severity of patient disease case mix in a hospital.
Teaching status: where academic hospitals are assigned a value of one and non-academic
hospitals are assigned a value of zero. Hospital age: we included the logarithm of hospital age as
a control variable in the estimation model. The literature suggests that newer hospitals may be
better in acquiring and using recent technologies than older hospitals (Devaraj & Kohli, 2003).
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Table 4. Models Variables
Variable

Measures

Objective one- Independent variables

EMR capabilities (CDR, CDSS, Binary variable which equals one if the hospital has
CPOE, order entry includes order adopted the technology during the study period.
communications,

and

physician The health IT application in EMR portfolio is coded as

documentation)

one if it is live and operational, and coded zero if the
health technology is not used.

Synergy between EMR capabilities It is calculated as the product of the health IT applications
(capabilities) in the portfolio.
EMR exploration

IT exploration is the number of EMR capabilities adopted
and used by each hospital. For example, if a hospital is
using CDR, CDSS, and order entry, while not using
CPOE

and

physician

documentation,

then

EMR

exploration equals 3 capabilities (i.e.∑ 1,1,1,0,0).
EMR exploitation

IT exploitation is defined as the “average years of
experience” with each of EMR capabilities. For example,
if a hospital’s years of experience with CDR, CDSS, and
order entry are: 10, 10, and 7 respectively then EMR
exploitation is 9 (i.e. AVG(10,10,7).

EMR Assimilation and use

The

complementarities

between

exploration

and

exploitation are measured as the product of EMR
capabilities exploration and exploitation (Setia et al.,
2011).
Objective Two- Independent variable
CPOEAdopt

It is a binary variable equal to one if a hospital adopted
CPOE before 2008, otherwise zero.

PDAdopt

It is a binary variable equal to one if a hospital adopted
physician documentation before 2008, otherwise zero.
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Objective Three10-Independent variable
EMRSEQDIS

Represents the distance between the observed sequence
and the EMR capabilities reference sequence.

The dependent variables, for objective 3-model 3, will be collected from 2012 database Medicare’s Hospital
Compare Database. The independent variables data is constructed from the 2005–2012 HIMSS Analytics database.
10
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CHAPTER 5
RESULTS
5.1 Objective 1 Results
5.1.1 Descriptive statistics

The descriptive statistics of hospital EMR capabilities, synergies, assimilation and use, and quality
outcomes performance are reported in Tables 5 and 7. In Table 5, for the panel data on all hospitals,
the highest adoption rate is for order entry followed by CDR and CDSS, and then CPOE and
physician documentation. Hospitals have invested the most in basic EMR portfolio including order
entry, CDSS, and CPOE capabilities. Among all of the hospitals in the panel, the mean quality
outcomes across the five health quality measures ranged from 11.26 to 24.80.

Table 5. Descriptive Statistics of Individual EMR Capabilities, EMR Capabilities
Portfolios, Hospital Characteristics, and Quality Outcomes Measures.
EMR Capability over Time (in Percentages)
Variable

HAM

HAR

HFM

HFR

PNM

PNR

PS

OE

91

73

90

90

90

90

86

CDSS

67

74

67

68

67

68

83

CDR

78

79

77

78

77

78

84

CPOE

29

42

29

30

29

30

34

PD

26

28

26

27

26

27

34

Basic EMR

57

48

56

58

56

57

77

Full EMR

21

22

20

22

20

22
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Hospital Characteristics*
Hospital size (log)

5.3

5.41

5.17

5.16

5.16

5.16

5.04

(0.69)

(0.64)

(0.76)

(0.77)

(0.77)

(0.77)

(0.86)
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CMI

1.42

1.47

1.39

1.40

1.39

1.39

1.39

(0.24)

(0.23)

(0.25)

(0.25)

(0.25)

(0.25)

(0.28)

For-Profit

0.22

0.21

0.22

0.22

0.22

0.22

0.22

Hospital Age (log)

3.42

3.44

3.39

3.38

3.39

3.38

3.36

(0.86)

(0.87)

(0.87)

(0.88)

(0.87)

(0.77)

(0.88)

0.06

0.06

0.05

0.05

0.05

0.05

0.05

Academic

* For all categorical variables proportion estimates are reported and for continuous variables
mean (standard deviation) is reported.
Quality Outcomes Performance over Time
Mean (Standard Deviation) Estimates of Quality Outcomes
Quality Measure

Mean ( Standard Deviation)

HAM: Heart Attack Mortality

16.07 (1.59)

HAR: Heart Attack Readmission

19.78 (1.73)

HFM: Heart Failure Mortality

11.26 (1.55)

HFR: Heart Failure Readmission

24.80 (2.14)

PNM: Pneumonia Mortality

11.74 (1.85)

PNR: Pneumonia Readmission

18.51 (1.69)

PS: Patient Satisfaction

67.31 (10.11)

We created multiple analytic datasets: an unbalanced panel spanning 2008-2012 where each
hospital must have at least two observations, and balanced panel dataset for each health condition
where each hospital must present in all years. The percentage of the balanced panel from the full
panel dataset is between 42 percent and 64 percent. The number of cross sections and length of
time series vary by health conditions as shown in the following Table.
Table 6: Description of the Panel Data, Length of Time Series, and Number of hospitals
across Health Conditions.
Quality
measure/Length
of time series
HAM
HAR
HFM
HFR

5*

4

3

2

Balanced

Unbalanced

689
NA
820
NA

242
657
255
899

199
217
203
255

178
205
192
247

689
657
820
899

1308
1079
1470
1401

44
PNM
825
259
204
195
PNR
NA
906
253
249
PS
810
640
268
223
*Length of time series (5 years, 4 years, 3 years, and 2 years)
Balanced: balanced panel
Unbalanced: unbalanced panel
NA: hospitals do not have data about the health condition.

825
906
810

1484
1408
1941

Table 7 shows the descriptive statistics of EMR capabilities assimilation and use, hospital
characteristics, and quality outcomes performance. Across all measures, the average EMR
exploration in all hospitals is about three EMR capabilities. The average hospital’s experience with
EMR capabilities is about 10.06 years. Finally, the average assimilation and use across all hospitals
is 29.03.

Table 7. Descriptive Statistics of Assimilation and Use, Hospital Characteristics, and Quality
Outcomes Measures.
EMR Capability Assimilation and Use
Variable

HAM

HAR

HFM

HFR

PNM

PNR

PS

EMR Exploration

2.93

2.99

2.90

2.95

2.90

2.95

3.34

(1.25)

(1.26)

(1.25)

(1.27)

(1.25)

(1.27)

(1.37)

9.98

10.32

10.05

10.19

10.04

10.17

9.68

(4.9)

(4.91)

(4.91)

(4.99)

(4.93)

(4.99)

(4.86)

EMR

28.34

29.76

28.35

29.04

28.32

29.00

30.42

Assimilation

(17.43)

(17.35)

(17.51)

(17.76)

(17.61)

(17.76)

(17.54)

EMR Exploitation

Hospital Characteristics*
Hospital size (log)

5.3

5.41

5.17

5.16

5.16

5.16

5.18

(0.69)

(0.64)

(0.76)

(0.77)

(0.77)

(0.77)

(0.79)

1.42

1.47

1.39

1.40

1.39

1.39

1.41

(0.24)

(0.23)

(0.25)

(0.25)

(0.25)

(0.25)

(0.26)

For-Profit

0.22

0.21

0.22

0.22

0.22

0.22

0.22

Hospital Age (log)

3.42

3.44

3.39

3.38

3.39

3.38

3.36

(0.86)

(0.87)

(0.87)

(0.88)

(0.87)

(0.77)

(0.88)

0.06

0.06

0.05

0.05

0.05

0.05

0.05

CMI

Academic
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* For all categorical variables proportion estimates are reported and for continuous variables
mean (standard deviation) is reported.
Quality Outcomes Performance over Time
Mean (Standard Deviation) Estimates of Quality Outcomes
Quality Measure

Mean ( Standard Deviation)

HAM: Heart Attack Mortality

16.07 (1.59)

HAR: Heart Attack Readmission

19.78 (1.73)

HFM: Heart Failure Mortality

11.26 (1.55)

HFR: Heart Failure Readmission

24.80 (2.14)

PNM: Pneumonia Mortality

11.74 (1.85)

PNR: Pneumonia Readmission

18.51 (1.69)

PS: Patient Satisfaction

67.80 (9.77)

5.1.2 Effect of synergy between EMR capabilities on hospital quality outcomes

In this study, we focus our analysis on the association between different capabilities of EMR
and patient quality care measures. The results of the panel data regressions are shown in Tables 8
and 9. Table 8 shows the results of the association between the synergetic impacts of EMR
capabilities on the quality of healthcare in the unbalanced dataset.
In the heart attack mortality column, the results on the impact of stand-alone individual
technologies on quality are not different from zero because the estimates are not statistically
significant except CDSS. The investment in CDSS as individual technology reduces the heart
attack mortality rate; the coefficient of CDSS is negative and significant (coeff. = 0.24, p < 0.05).
However, we observe that the synergy between all EMR capabilities (full EMR capabilities) is
associated with lower heart attack mortality rate (coeff. = -0.17, p < 0.05), the coefficient is
negative and significant.
In the heart failure mortality column, we also observe a significant association between full
EMR capabilities synergetic impact and a lower heart failure mortality rate (coeff. = -0.13, p <
0.1). However, the results on the impact of stand-alone individual technologies on quality are not
different from zero because the estimates are not statistically significant.
We also observe that, in the pneumonia readmission column, the synergy between basic EMR
capabilities reduces pneumonia mortality rate by 0.22 (p < 0.1), and this cannot be achieved from
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the investment in EMR capabilities as stand-alone individual technologies. For example, the
investment in CDSS as a stand-alone technology is associated with an increase in the pneumonia
readmission rate. The coefficient is positive and significant (coeff. = 0.25, p < 0.05). Moreover,
we note that the synergy among full EMR capabilities portfolio increases patient satisfaction by
1.33 (p < 0.01), and this cannot be achieved from the investment in EMR capabilities as standalone individual technologies. For example, the investment in CDSS, CPOE, and PD as standalone technologies is associated with a decrease in the level of patient satisfaction. The coefficients
are negative and significant.
Further, in heart attack readmission, heart failure readmission and pneumonia mortality rates,
we do not observe a significant relationship between the synergy among any EMR capabilities
portfolios and pneumonia mortality and the two readmission rates.

Table 8. Estimation of the effects of the synergy between the portfolios of EMR capabilities
on healthcare quality outcomes at U.S. Hospitals (Unbalanced Panel; 2008-2012)
Variable

HAM

HAR

HFM

HFR

PNM

PNR

PS

Order Entry

0.01

0.19**

-0.03

0.20

-0.19*

0.17

-0.37

CDSS

-0.24**

0.04

0.01

-0.02

0.07

0.25**

-0.88**

CDR

-0.07

-0.21**

0.02

-0.02

0.004

-0.15

0.08

CPOE

0.01

-0.08*

0.07

-0.11

0.04

-0.08

-0.61***

Physician

0.03

-0.11

0.02

-0.15

0.02

-0.10

-0.47*

-0.12

0.10

-0.22*

-0.06

Documentation
The Synergy Between Basic EMR Capabilities
Basic EMR

0.06

-0.07

0.02

The Synergy Between Full EMR Capabilities
Full EMR

-0.17**

0.06

-0.13*

0.20

-0.83

-0.03

1.33***

0.23

0.14

0.20

0.24

0.18

0.28*

-0.87

-0.75***

-0.55*

-0.70***

-1.89**

-0.91***

-1.0***

3.87***

Control variables
Hospital size
(log)
Case mix
index
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For-Profit

0.14

-0.26*

0.14

0.28*

0.16

0.01

0.01

0.11

-0.10

0.09

-0.08

0.16

-0.01

-0.87

0.18

0.19

-0.18

0.52**

0.15

0.85***

-0.52

R-Square

0.71

0.77

0.73

0.82

0.74

0.80

0.86

F Value

7.10***

7.35***

8.53***

9.66***

8.66***

9.01***

15.16***

Cross Sections

1308

1079

1470

1401

1484

1408

1941

Hospitals
Hospital Age
(log)
Academic
Hospitals

#
* = significance at p < 0.10, **=p < 0.05, and ***=p < 0.01

Examining the influence of the control variables on quality of healthcare, we note that large
hospitals are associated with higher rates of pneumonia readmission. CMI reveals that hospitals
handling more complex cases with greater patient severity exhibit lower levels of mortality and
readmission rates in all health conditions as well as higher patient satisfaction. Examining the
relationship between hospital type and quality outcomes, we observe that for-profit hospitals
exhibit a lower level of heart attack readmission while not for-profit hospitals are associated with
lower rate of heart failure readmission. Further, academic hospitals exhibit higher rates of heart
failure readmission and pneumonia readmission.

Table 9 shows the results of the association between the synergetic impacts of EMR
capabilities on the quality of healthcare in the balanced dataset.
In the heart attack mortality column, the results on the impact of stand-alone individual
technologies on quality are not different from zero because the estimates are not statistically
significant except CDSS. The investment in CDSS as individual technology reduces the heart
attack mortality rate; the coefficient of CDSS is negative and significant (coeff. = -0.33, p < 0.05).
However, we observe that the synergy between all EMR capabilities (full EMR capabilities) is
associated with a lower heart attack mortality rate (coeff. = -0.17, p < 0.1), the coefficient is
negative and significant.
In the heart failure readmission column, we observe that the synergy between basic EMR
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capabilities portfolio is associated with a lower heart failure rate. The coefficient is negative and
significant (coeff= -0.30, p < 0.1). However, the performance impacts of the individual
technologies vary by technology. For example, the investment in OE is associated with a higher
hear failure readmission rate. The coefficient is positive and significant (coeff=0.45, p < 0.01).
While the investment in PD as a stand-alone individual technology reduces the heart failure
readmission rate. The coefficient is negative and significant (coeff=-0.30, p < 0.01).
Moreover, we note that the synergy among full EMR capabilities portfolio increases patient
satisfaction level by 0.87 (p < 0.05), and this cannot be achieved from the investment in EMR
capabilities as stand-alone individual technologies. For example, the investment in OE, and CDSS
as stand-alone technologies is associated with a decrease in patient satisfaction. The coefficients
are negative and significant.
However, we observe that the synergy between EMR capabilities is not significantly
associated with heart attack readmission, heart failure mortality, pneumonia mortality, and
pneumonia readmission rates.

Table 9. Estimation of the effects of the synergy between the portfolios of EMR capabilities
on healthcare quality outcomes at U.S. Hospitals (Balanced Panel; 2008-2012)
Variable

HAM

HAR

HFM

HFR

PNM

PNR

PS

Order Entry

-0.03

0.19**

-0.02

0.45***

-0.03

0.35***

-0.86*

CDSS

-0.33**

0.05

-0.01

0.13

0.24*

0.13

-0.73*

CDR

-0.18

-0.22**

-0.06

0.02

-0.06

-0.23*

-0.14

CPOE

0.03

-0.06

0.08

-0.16

0.04

-0.07

-0.28

Physician

0.02

-0.15*

0.04

-0.30***

-0.11

-0.08

-0.04

-0.30*

-0.02

-0.21

0.19

0.39

-0.02

0.03

0.87**

Documentation
The Synergy Between Basic EMR Capabilities
Basic EMR

0.07

-0.04

0.03

The Synergy Between Full EMR Capabilities
Full EMR

-0.17*

Control Variables

0.08

-0.10
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Hospital size

0.02

0.12

0.09

0.21

0.06

0.23

0.13

-1.01*** -0.46

-0.51*

-2.21***

-1.18*** -1.01***

4.10***

0.09

-0.15

0.30**

0.17

0.25*

0.08

0.30

0.14

-0.07

-0.01

-0.21

0.06

-0.01

0.48

0.30*

0.18

-0.21

0.44*

0.15

0.86***

-1.43**

R-Square

0.68

0.76

0.71

0.81

0.71

0.79

0.83

F Value

7.86***

8.29***

9.30***

10.19*** 9.35***

9.78***

15.14***

Cross Sections

689

657

820

899

906

810

(log)
Case mix
index
For-Profit
Hospitals
Hospital Age
(log)
Academic
Hospitals

825

#
* = significance at p < 0.10, **=p < 0.05, and ***=p < 0.01

Examining the influence of the control variables on the quality of healthcare, CMI reveals that
hospitals handling more complex cases with greater patient severity exhibit lower rates of mortality
and readmission in almost all quality measures. We also observe that for-profit hospitals exhibit
higher level of heart failure mortality and pneumonia mortality. Furthermore, academic hospitals
are associated with higher rates of heart attack mortality, heart failure readmission and pneumonia
readmission as well as lower level of patient satisfaction.

5.1.3 Effect of EMR capabilities assimilation and use on hospital quality outcomes

In the second sub-objective, we focus our analysis on the association between the assimilation
and use of EMR capabilities and patient quality care measures. The results of the panel data
regressions are shown in Tables 10 and 11. Table 10 shows the results of the association between
the impacts of EMR capabilities assimilation and use on the quality of healthcare in the unbalanced
dataset.
We observe that greater assimilation and use of EMR capabilities is significantly associated
with only one quality measure-pneumonia mortality rate (coeff. = -0.01, p < 0.05). However, we
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do not observe that assimilation and use of different EMR capabilities is significantly associated
with the heart attack mortality rate, heart attack readmission rate, heart failure readmission rate,
pneumonia readmission rate, and level of patient satisfaction. Further, we observe that higher EMR
exploration is associated with lower rates of heart attack mortality, heart attack readmission, and
pneumonia readmission. The coefficients are negative and significant.
Examining the influence of the control variables on the quality of healthcare, we observe that
large hospitals are associated with higher rates of pneumonia readmission. An examination of CMI
reveals that hospitals handling more complex cases with greater patient severity exhibit lower rate
of mortality and readmission in all conditions as well as higher patient satisfaction. Examining the
relationship between hospital type and quality outcomes, we observe that for-profit hospitals
exhibit higher rate of heart failure readmission and level of patient satisfaction, and lower rate of
heart attack readmission. Further, academic hospitals are associated with higher rate of pneumonia
readmission

Table 10. Estimation of the Effects of the Assimilation and Use of EMR Capabilities on
Healthcare Quality Outcomes at U.S. Hospitals (Unbalanced Panel; 2008-2012)
Variable

HAM

HAR

HFM

HFR

PNM

PNR

PS

EMR

-0.09**

-0.10**

0.02

-0.05

0.105**

-0.09**

-0.30

-0.01

-0.01

0.005

0.003

0.03***

-0.01

-0.02

Assimilation

0.001

0.004

-0.003

0.004

-0.01**

0.004

0.01

Hospital size

0.23

0.12

0.20

0.24

0.22

0.26*

0.06

Case mix index

-0.75**

-0.63**

-0.69**

-1.82**

-0.86***

-1.09**

6.79***

For-Profit

0.31

-0.31*

0.13

0.29*

0.16

-0.02

2.11**

0.10

-0.10

0.09

-0.07

0.15

-0.01

0.67

0.12

0.26

-0.12

0.39

0.13

0.89***

-1.22

Exploration
EMR
Exploitation

(log)

Hospitals
Hospital Age
(log)
Academic
Hospitals
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R-Square

0.71

F Value
Cross Sections #

0.77

0.73

0.82

7.09*** 7.33***

8.57***

1305

1465

1076

0.74

0.80

0.87

9.71*** 8.66***

9.01***

16.13***

1395

1402

888

1479

* = significance at p < 0.10, **=p < 0.05, and ***=p < 0.01

Table 11 shows the results of the association between the impacts of EMR capabilities
assimilation and use on the quality of healthcare in the balanced dataset.
As shown in Table 11, we do not find a statistically significant association between EMR
capabilities assimilation and use and quality outcomes measures. In particular, we do not observe
that assimilation and use of different EMR capabilities is significantly associated with the heart
attack mortality rate, heart attack readmission rate, heart mortality rate, heart failure readmission
rate, pneumonia mortality rate, pneumonia readmission rate, and level of patient satisfaction. In
our study, we measured the effect of EMR assimilation and use in only seven quality measures.
However, Health IT may well improve other aspects of quality unmeasured by our data. Further,
we observe that higher EMR exploration is associated with a lower heart attack mortality rate and
pneumonia readmission rate. The coefficients are negative and significant.
Furthermore, an examination of CMI reveals that hospitals handling more complex cases with
greater patient severity exhibit lower rates of all health quality outcomes measures as well as higher
patient satisfaction. Moreover, for-profit hospitals are associated with a higher level of patient
satisfaction while not for-profit hospitals exhibit a lower heart failure mortality rate. Finally,
academic hospitals are associated with a higher heart attack mortality rate.

Table 11. Estimation of the Effects of the Assimilation and Use of EMR Capabilities on
Healthcare Quality Outcomes at U.S. Hospitals (Balanced Panel; 2008-2012)
Variable

HAM

HAR

HFM

HFR

PNM

PNR

PS

EMR

-0.12**

0.08

0.02

-0.4

0.06

-0.12*** -0.26

-0.01

0.04**

0.01

0.01

0.03

-0.02

0.09

0.001

-0.01

-0.002

0.001

-0.001

0.01

0.002

Exploration
EMR
Exploitation
Assimilation
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Hospital size

0.03

0.08

0.08

0.21

0.29

0.22

0.37

Case mix index

-0.99***

-1.36***

-0.51*

-2.14***

-1.19***

-1.39***

7.40***

For-Profit

0.07

0.25

0.30**

0.17

0.17

0.07

2.98**

0.14

0.04

-0.002

0.21

0.02

-0.04

0.32

0.37*

0.12

-0.14

0.3

0.05

0.91

-0.92

R-Square

0.68

0.71

0.71

0.81

0.71

0.78

0.83

F Value

7.93***

9.28***

9.37***

10.25*** 9.40***

9.83***

15.12***

Cross Sections #

689

825

820

892

899

391

(log)

Hospitals
Hospital Age
(log)
Academic
Hospitals

624

* = significance at p < 0.10, **=p < 0.05, and ***=p < 0.01

5.2 Objective 2 Results

In the next section, we describe our analysis of the impact of advanced EMR capabilities early
adoption on quality measures. The descriptive statistics are reported in Appendix D, Tables A and
B.
5.3.1 Quality improvements from early investment in CPOE

The results of the regression model are shown in Table 12. Table 12 shows the results of the
impact of the early investment in CPOE on healthcare quality measures. In the heart attack
mortality column, we observe that the early adoption of CPOE is associated with lower heart attack
mortality rate (coeff. = -0.231, p < 0.05), the coefficient is negative and significant. We observe a
similar association between early adoption of CPOE and a lower heart failure readmission rate
(coeff. = -0.324, p < 0.05), the coefficient is negative and significant. In the heart failure mortality
column, we do not observe a significant relationship between early investment in CPOE and the
heart failure mortality rate. In the pneumonia mortality column, we also observe a similar
significant association between the early investment in CPOE and a lower pneumonia mortality
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rate. In particular, the hospitals that invested early in CPOE were able to reduce the pneumonia
mortality rate by -0.395. The coefficient is negative and significant at 0.1. In the pneumonia
readmission columns, we also observe that early investment in CPOE results in a lower pneumonia
readmission rate (coeff. = -0.239, p < 0.1).
In the patient satisfaction column, we note a significant association between early investment
in CPOE and higher level of patient satisfaction, the coefficient is positive and significant (coeff.
= 2.028, p < 0.05). That means early investment in CPOE increased patient satisfaction by 2.028.
Examining the relationship between hospital size and quality measures, we note that larger
hospitals are more likely to exhibit lower rates of heart attack mortality, heart failure mortality and
pneumonia mortality, while smaller hospitals are associated with lower rates of heart failure
readmission, pneumonia readmission and a higher level of patient satisfaction. Furthermore, in
evaluating the relationship between hospital age and quality, we find that old hospitals are
associated with higher rates of heart failure mortality and pneumonia mortality.
An examination of CMI reveals that hospitals handling more complex cases with greater
patient severity exhibit lower rates of heart attack mortality, heart failure readmission, pneumonia
readmission as well as higher level of patient satisfaction. We also note that academic hospitals
are associated with a lower rates of heart attack and heart failure mortality, while non-academic
hospitals are associated with lower heart failure and pneumonia readmission rates. Finally, our
results indicate that for-profit hospitals exhibit lower heart failure mortality rate and patient
satisfaction, and higher rates of heart attack mortality and heart failure readmission.

Table 12. Estimation of the Effects of Early Adoption of CPOE on Quality of Care
Variables

HAM

HFR

HFM

PNM

PNR

PS

Constant

18.19***

28.35***

11.12***

12.021*** 20.38***

65.28***

CPOE

-0.231**

-0.324**

-0.088

-0.395*

-0.239*

2.028***

Hospital Size

-0.176***

0.391***

-0.253***

-0.189***

0.435***

-4.348***

-0.008

-0.019

0.075**

0.112***

0.005

0.122

CMI

-0.943***

-3.059***

0.250*

-0.186

-2.028***

16.790***

Maturity

0.024

0.032

-0.012

0.023

0.003

-0.240**

(log)
Hospital Age
(log)
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Academic

-0.3**

1.320***

-0.544***

-0.132

1.233***

0.532

For-Profit

0.215**

0.494***

-0.147

0.042

0.143

-4.780***

R Square

.077

0.121

0.045

0.023

0.081

.140

Adjusted R

.075

0.119

0.042

0.020

0.079

.138

F

34.54***

56.87***

18.37***

9.24***

36.99***

62.63***

N

2912

2912

2912

2912

2912

2688

Hospitals

5.3.2 Quality improvements from early investment in physician documentation

The results of the regression model are shown in Table 13. Table 13 shows the results of the
impact of the early investment in physician documentation on healthcare quality measures. In the
heart attack mortality column, we observe that the early adoption of physician documentation is
associated with a lower heart attack mortality rate (coeff. = -0. 203, p < 0.1), the coefficient is
negative and significant. We observe a similar significant association between early adoption of
physician documentation and a lower heart failure readmission rate (coeff. = -0. 277, p < 0.05),
the coefficient is negative and significant. In the heart failure mortality column, we do not observe
a significant relationship between early investment in physician documentation and the heart
failure mortality rate. In the pneumonia mortality column, we also observe a significant association
between the early investment in physician documentation and a lower pneumonia mortality rate.
In particular, the hospitals that invested early in physician documentation were able to reduce
pneumonia mortality rate by -0.444. The coefficient is negative and significant at 0.01. In the
pneumonia readmission columns, we also observe that early investment in physician
documentation results in a lower pneumonia readmission rate (coeff. = -0.332, p < 0.01).
In the patient satisfaction column, we observe a significant association between early
investment in physician documentation and higher level of patient satisfaction, the coefficient is
positive and significant (coeff. = 1.942, p < 0.01). That means early investment in physician
documentation increased patient satisfaction by 1.942.
Examining the relationship between hospital size and on quality measures, we note that larger
hospitals are more likely to exhibit lower rate of heart failure mortality, while smaller hospitals are
associated with lower rates of heart attack mortality, heart failure readmission, pneumonia
mortality, pneumonia readmission as well as higher level of patient satisfaction. Furthermore, in
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evaluating the relationship between hospital age and quality, we find that old hospitals are
associated with higher rate of heart failure mortality.
An examination of CMI reveals that hospitals handling more complex cases with greater
patient severity exhibit lower rates of heart attack mortality, heart failure readmission, pneumonia
mortality, pneumonia readmission as well as a higher level of patient satisfaction. We observe that
physician documentation that has been adopted since a long period of time are associated with
higher rates of heart attack mortality, heart failure readmission, pneumonia mortality, pneumonia
readmission as well as a lower level of patient satisfaction. We also note that academic hospitals
are associated with lower rates of heart attack and heart failure mortality, while non-academic
hospitals are associated with lower heart failure readmission, pneumonia mortality and pneumonia
readmission rates. Finally, our results indicate that for-profit hospitals are associated with higher
heart attack mortality rate, heart failure readmission, pneumonia mortality, pneumonia
readmission rates as well as lower patient satisfaction.

Table 13. Estimation of the Effects of Early Adoption of PD on Quality of Care
Variable

HAM

HFR

HFM

PNM

PNR

PS

Constant

15.714*** 26.881*** 12.037*** 17.996*** 18.814*** 65.959***

PD

-0.203*

-0.277**

0.075

-0.444***

-0.332***

1.942***

Hospital Size (Log) 0.259***

0.414***

-0.265***

0.684***

0.442***

-4.281***

Hospital Age(Log)

-0.012

-0.018

0.062**

0.016

-0.015

0.071

CMI

-0.579***

-3.319***

0.195

-2.476***

-2.054***

16.758***

Maturity

0.028**

0.026*

-0.011

0.035**

0.033**

-0.230***

Academic

-0.718***

1.421***

-0.701***

1.087***

1.213***

0.625

For-Profit

0.234**

0.548***

-0.075

0.181*

0.143*

-4.729***

R Square

0.022

0.120

0.041

0.086

0.083

0.140

Adjusted R

0.020

0.118

0.039

0.084

0.081

0.138

F

9.96***

59.68***

18.70***

41.11***

39.60***

62.12***

N

3059

3059

3059

3059

3060

2670

Hospitals
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5.3 Objective 3 Results
As stated in the methodology section, we tracked all hospitals sequences from 2005-2012, and
identified the order of EMR capabilities adoption that correspond to the best performer hospitals
(reference sequences). This process yields seven EMR capabilities adoption sequences as shown
in Table 14.

Table 14. EMR capabilities adoption reference sequences
Reference sequence

Number of
hospitals in the
sample data set

CDR-CDSS-OE-CPOE-PD
CDR-CDSS-OE-PD-CPOE
CDR-OE-CDSS-CPOE-PD
CDSS-CDR-OE-CPOE-PD
CDSS-OE-CDR-CPOE-PD
OE-CDR-CDSS-CPOE-PD
OE-CDR-CDSS-PD-CPOE

5
3
5
7
3
21
16

Sequence analysis provides insights about how close each hospital’s adoption pattern of EMR
capabilities is to the EMR capabilities adoption reference sequences. As presented in Table 14, we
observe that all the reference sequences started with basic EMR capabilities first, and then
advanced EMR capabilities last. This is largely consistent with HIMSS EMRAM discussed in
section (2.3). Moreover, we find that about 16 percent of the hospitals in the sample dataset
followed (OE-CDR-CDSS-CPOE-PD) sequence and 12 percent of hospitals with (OE-CDRCDSS-PD-CPOE) sequence. This result is largely consistent with the logical dependency of EMR
capabilities discussed in section (2.3).
Descriptive statistics are presented in Table 15. Across all hospitals in the dataset, the mean
quality measures ranged from 11.65 to 24.38. On average, the Levenshtein distance from the EMR
capabilities adoption reference sequences is about 1.10 in all quality measures.
Further, we conducted two procedures to investigate the relationship between EMR
capabilities adoption sequences and healthcare quality. First, we compared the means of various
quality measures as dependent variables and EMR capabilities adoption sequences as independent
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variable as shown in Table 16. The results show that the hospitals with EMR capabilities adoption
reference sequences perform better on all three quality measures than the other EMR capabilities
adoption sequences. They had lower readmission and mortality rates than other hospitals.

Table 15. Descriptive Statistics in the Sample Dataset
Variable

HFR

HFM

PNM

Mean (SD)

Mean (SD)

Mean (SD)

Mortality/Readmission 24.38 (1.76)

11.65 (1.81)

11.85 (2.11)

rates
SeqDist

1.10 (1.05)

1.12 (1.06)

1.09 (1.05)

Hospital Size (Log)

2.3 (0.34)

2.3 (0.34)

2.3 (0.34)

Hospital Age (Log)

1.47 (0.43)

1.47 (0.43)

1.47 (0.43)

CMI

1.48 (0.28)

1.48 (0.28)

1.48 (0.28)

Academic

Proportional
Estimate
0.03

Proportional
Estimate
0.03

Proportional
Estimate
0.03

For-profit

0.12

0.12

0.12

Table 16. Compare Means Results for Performance of EMR Capabilities Reference
Sequences
HFM

PNM

HFR

EMR capabilities Mean

11.380

11.772

24.131

Reference

N

54

54

54

Sequences

Std.

1.8796

2.2805

1.7185

Mean

11.845

11.907

24.555

N

76

76

76

Std.

1.7544

1.9943

1.7898

Deviation
Other Sequences

Deviation
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Next, we estimated OLS regression model for each quality measure with independent
variable- SeqDist, quality measures as dependent variables, and control variables. This study did
not have sufficient data for heart attack mortality, heart attack readmission, pneumonia
readmission and patient satisfaction quality outcomes measures. Therefore, we examined the
impact of EMR capabilities adoption sequence distance on heart failure readmission, heart failure
mortality, and pneumonia mortality rates. For ease of interpretation, we reversed the distance
measures (5 – SeqDist=EMRSEQ) 11. In the first row of Table 17, we observe that EMRSEQ
relates significantly to two quality measures after controlling for other factors. Hospitals that
closely follow reference EMR capabilities adoption sequences were able to reduce heart failure
mortality rate by -0.30. The coefficient is negative and significant (p < 0.05). We also observe that
these hospitals that closely match with reference EMR capabilities adoption sequences
experienced a lower pneumonia mortality rate than other hospitals by -0.32. The coefficient is
negative and significant (p < 0.1).

Table 17. Estimation of the Effects of EMR Capabilities Implementation Sequence on
Quality of Care

11

Variable

HFR

HFM

PNM

Constant

26.86***

14.53***

14.24***

EMRSEQ

-0.30**

0.02

-0.32*

Hospital Size (Log)

1.24*

-0.01

-1.08

Hospital Age (Log)

-0.08

0.06

0.97**

CMI

-2.79***

-2.11**

-0.19

Academic

0.91

0.19

-0.25

For-Profit Hospitals

0.67

0.72

1.59***

R Square

0.16

0.13

0.15

Adjusted R

0.12

0.09

0.10

F

3.94***

3.12***

3.48***

N

130

130

130

The maximum number of operations to transform any sequence is five.
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Examining the relationship between hospital size and quality outcomes, we observe that large
hospitals are associated with a higher failure readmission rate. We also note that old hospitals are
associated with a higher pneumonia mortality rate. An examination of CMI reveals that hospitals
handling more complex cases with greater patient severity exhibit lower rates of heart failure
readmission and heart failure mortality. Finally, our results indicate that for-profit hospitals are
associated with a higher pneumonia mortality rate.
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CHAPTER 6
DISCUSSION AND CONCLUSION
6.1 Discussion
In this dissertation, we studied three different aspects of EMR implementations that include
the exploration of synergy between EMR capabilities, the impact of early adoption of EMR
capabilities, and the optimal sequence of EMR capabilities adoption. We also tested the impact of
these dimensions on various healthcare quality outcomes measures.
In exploring the relationship between the synergy among different portfolios of EMR
capabilities and quality outcomes of care at U.S. hospitals, we employed a panel dataset for the
period (2008-2012) to examine how the synergy between different EMR capabilities
implementations impacts quality compared to the impact of individual EMR capabilities
investment. More specifically, whether the synergy between EMR capabilities is capable of
achieving better quality of care compared to stand-alone EMR capabilities investment. Overall,
we found that the synergy between full EMR capabilities is capable of achieving better quality
than stand-alone individual EMR systems.
This study contributes to our understating of emerging health IT in some important ways. To
our knowledge, this study is one of the first to quantify the association between the synergy among
different EMR systems implementations with quality outcomes measures. This study also applies
panel data analysis to conduct a more granular and comprehensive examination that enumerates
the impact of EMR capabilities on care quality outcomes using panel data for five years period
from 2008 to 2012.
Our findings also have significant implications for hospitals’ CIOs since the results provide
empirical evidence on the effectiveness of measuring the impact of the synergy and assimilation
and use of EMR capabilities on healthcare quality outcomes.
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The findings, however, indicated variations in the performance impact of EMR capabilities
assimilation and use on healthcare quality. We found the greater assimilation and use of EMR
capabilities are only associated with reducing pneumonia mortality conditions’ negative effects.
We did not find a statistically significant association between EMR capabilities assimilation and
use and heart attack mortality rate, heart attack readmission rate, heart mortality rate, heart failure
readmission rate, pneumonia readmission rate, and level of patient satisfaction. However, Health
IT may well improve other healthcare outcomes unmeasured by our data.
Second, our study results also suggest that early-adopter hospitals were able to improve
healthcare quality as a result of advanced EMR adoption. In fact, early adoption was associated
with a decrease in mortality and readmission rates as well as higher patient satisfaction, which
means higher quality of healthcare.
Another significant finding of our study pertains to the consistent pattern in the impacts of
hospital age, technology maturity, and CMI. Old hospitals are more likely to report high mortality
and readmission rates, which means lower healthcare quality. We also observe that the physician
documentation that has been adopted since a long period of time have negative impact on the
quality measures. This might because the technology advancement issue. For instance, 2008
physician documentation is more advanced than 2005 physician documentation version. Finally,
we note that case mix index has a significant impact on improving almost all quality measures
such hospitals that treat patients with more complex cases exhibit higher quality rates.
These results on early adoption have important implications for policy makers since they
provide empirical evidence on the positive impact of early adoption of advanced EMR capabilities
on various healthcare quality measures. To the best of our knowledge, our study is the first to
estimate the impact of early adoption on healthcare quality outcomes from the investment in EMR
capabilities.
Third, in this study, we tracked the sequences of EMR capabilities adoption longitudinally
across U.S. hospitals and assessed their impact on healthcare quality outcomes. Our results on
EMR capabilities adoption reference sequences are largely consistent with the seven-stage HIMSS
EMRAM. The EMR capabilities adoption patterns results showed that best performer hospitals
adopted basic EMR capabilities first while advanced EMR capabilities were adopted later in the
sequence. The analysis provides support for our assumption about EMR sequence analysis. The
assumption posits that EMR capabilities adoption sequences do matter and have an impact on
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healthcare quality. The analysis shows that hospitals that closely follow reference EMR
capabilities adoption sequences experienced better quality outcomes than other hospitals.
According to McKinsey (2002), IT does matter and it has an impact on productivity. However, the
extent of this impact depends on how it is employed. When implemented in an appropriate
sequence, its impact on productivity can be large.
Our results provide useful insights and important implications for management. For example,
the closer a hospital adheres reference EMR sequences, the better the quality outcomes. Thus, we
believe that this is an actionable finding and hospital’s CIOs or decision makers can help determine
optimal EMR capabilities adoption patterns from these findings as well. Moreover, knowing the
reference EMR capabilities adoption sequence would cut implementation time and cost, as well as
reduce uncertainties associated with the next application to adopt. The results suggest strategies
for EMR capabilities adoption to help decide which systems may be best implemented first. In
the context of this study, best-performer hospitals adopted basic EMR capabilities first, and then
more advanced EMR capabilities were implemented last. On the other hand, the findings of this
study provide better guidelines for meaningful use about the best order of EMR capabilities
adoption and how adoption patterns potentially impact hospital’s performance.
To our knowledge, this study is the first paper to explicitly examine the sequence of EMR
capabilities adoption using longitudinal data and assess the impact of the sequence of adoption on
healthcare quality measures. Another important contribution of this study is our methodology in
identifying EMR capabilities adoption reference sequences in relation to hospital performance.
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6.2 Limitations
This study has the following limitations. First, the effect of EMR capabilities implementation
may be biased due to endogeneity. While fixed effects models control for all observed and
unobserved time-invariant characteristics of the hospitals, our results may still be biased by the
presence of time-varying unobserved effects that occurred concurrently with EMR. Potential
confounders that might impact healthcare outcomes apart from the effects of the portfolio of EMR
capabilities include: care delivery models and quality improvement (QI) initiatives (Tiedeman &
Lookinland, 2004; Weiner et al., 2006), organizational and management strategies, and physicians’
perception of EMR use (Lee et al., 2013).
Second, the study does not address other related issues of importance. Due to the constraints
of the dataset, we were unable to examine the effect of the EMR capabilities on other outcomes
such adverse drug events, length of stay, and myocardial infarction (AMI). Moreover, our variables
in the synergy objective are based on a binary scale. This measure may not fully capture the actual
effect of the synergy among EMR capabilities. An augmented measure of synergy would be a
potentially interesting avenue for future research.
Third, on the impact of early adoption of advanced EMR capabilities on healthcare quality,
this study fails to determine whether the impact of early adoption on quality outcomes from the
investment in EMR capabilities resulted in sustained improvement in quality outcomes.
Moreover, a limitation of a longitudinal study is that it is not easy to specify other possible
explanations for the findings. Although we control for many hospital characteristics, it could still
be that the better managed hospitals were early adopters and that quality improvements are the
results of better management, rather than investment in EMR capabilities. Such studies are also
hampered by the difficulty of obtaining the necessary data (Dos Santos & Peffers, 1993). Usually,
panel data is difficult to obtain, and good secondary data sources are rarely available.
Fourth, in Objective 3, our analysis does not suggest that there is a causal relationship between
EMR adoption patterns and quality outcomes. It is likely that other factors such as management
factors could have impact on quality outcomes. This deserves further investigation in future
studies. Moreover, this study was missing data on some quality measures. Therefore, we were not
able to analyze the impact of EMR adoption patterns on several other quality outcome measures
previously mentioned in this study.
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6.3 Conclusion and Future Work
This research is extending earlier work on the benefits of EMR technology by focusing on the
synergistic impact of different EMR capabilities on healthcare quality. This is one of the first
studies to examine the relative performance contributions of different capabilities of EMR and
their impact on outcomes and patient levels measures of healthcare quality of care. The results
highlight that hospitals should consider the synergy between EMR capabilities to realize greater
quality performance. On the other hand, hospitals should explore many EMR capabilities and
develop deep experience with different EMR capabilities in order to realize lower pneumonia
mortality.
This study also sought to determine whether early adopters of advanced EMR capabilities
were able to improve the quality of healthcare. More specifically, the results suggest that early
advanced EMR capabilities were able to improve the quality outcomes relative to hospitals that
were not early adopters.
This research also answers the question whether the adoption path of EMR capabilities
impacts healthcare quality outcomes. Our results suggest that the sequence of EMR capabilities
adoption does matter. This finding provides valuable insights as hospitals aim to show the value
derived from health IT investments. This study empirically shows improvement in quality
outcomes when hospitals follow the optimal sequence of EMR capabilities adoption.
Future studies on health IT may benefit from measuring the impact of synergy between EMR
capabilities as well their assimilation and use on other quality measures such as process quality
outcomes. It may also be useful to study the impact of the synergy between EMR capabilities on
other performance measures such as cost and efficiency.
On the early adoption results, it is recommended to further explore whether the impact of early
adoption from advanced EMR capabilities investment is sustained for the years after the early
adoption period. This research also suggests that it may be useful to explore the impact of EMR
capabilities adoption patterns using additional performance measures and quality measures such
as length of stay.
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APPENDICES
APPENDIX A: Healthcare Quality Outcomes Measures

Readmission and Deaths12

Description

-

They measure the complication,
injuries, or other certain conditions
happened to patients after they got
hospital care.

-

30-days readmission rates focus on
whether patients were readmitted
again to the hospitals within 30 days
of discharge.

-

30-days mortality rates “focus on
whether patients died within 30 days
of being admitted to the hospital”.

Calculation

The calculation of readmission and death
rates is based on the followings:
-

Medicare enrollment,

-

Claims records, and

-

Specific statistical procedure such as
hierarchical logistic regression model.

-

The calculation considers how sick
patients when they were first admitted
to the hospital13.

Why they are important?

-

Shows hospitals’ performance
compare to the national rate.

12
13

https://www.medicare.gov/HospitalCompare/Data
This is known as “risk-adjusted” and helps make the comparisons between hospitals accurate and meaningful.
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o If the readmission and death
rates are lower than national
rates then hospital’s
performance is better than
national rate.
o If the readmission and
mortality rates are higher than
national rates then hospital’s
performance is worse than
national rate.
o If readmission and mortality
rates are same as national rates
then hospital’s performance is
no different than the national
rate.
-

Mortality rates “provide information
about important aspects of hospital
care that affect patients’ outcomeslike prevention of and response to
complications, emphasis on patient
safety, and the timeliness of care.”

-

Readmission rates provide
information about hospital’s
performance in preventing
complications, clear information to the
patients about discharge instructions,
and help patients make an easy
transition to their home.
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Patient satisfaction

Description

-

HCAHPS (Hospital consumer
assessment of healthcare providers
and systems): “is a standardized
survey instrument and data collection
methodology that has been in use
since 2006 to measure patients’
perspectives of hospital care.”

-

Hospital Compare website shows the
survey results. This helps consumers
make comparisons between hospitals
on important aspects of patients’
perspectives of treatment and care.

Survey methodology

-

The sample are chosen randomly from
recently discharged adult patients.

-

The survey includes questions about
patients’ feedback about topics such as
nurses and doctors communication
and hospital environment.

Survey topics

-

“How often did nurses communicate
well with patients?”

-

“How often did doctors communicate
well with patients?”

-

“How often did patients receive help
quickly from hospital staff?”

-

“How often was patients’ pain well
controlled?”

-

“How often did staff explain about
medicines before giving them to
patients?”
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-

“How often were the patients’’ rooms
and bathrooms kept clean?”

-

“How often was the area around
patients’ rooms kept quiet at night?”

-

“Were patients given information
about what to do during their recovery
at home?”

-

“How well did patients understand the
type of care they would need after
leaving the hospital?”

-

“How do patients rate the hospital
overall?”

-

“Would patients recommend the
hospital to friends and family?”
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APPENDIX B: Datasets Merging Process
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Tables and Fields
HIMSS Analytic Database

Table Name

Description

Fields

Description

HAEntity

HAEntity table contains

HAEntityid

“Identification

demographic information

number associated

for all facilities in the

with surveyed

database.

entity. Unique
within survey year.”
Name

Facility's Name

HAEntityType

Description of
facility type (e.g.,
Ambulatory,
Hospital, Home
Health, etc.)

MedicareNumber

Medicare
identification
number

State

State where facility
is located

Zip

Facility's Postal Zip
Code

Type

Description of the
facilities primary
service provided
(e.g., Academic,
Psychiatric,
Diabetes Center,
etc.)
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YearOpened

Year Facility was
acquired

OwnershipStatus

Ownership Status;
“Owned, Managed,
Leased, or
Affiliated”

NofBeds

Number of Licensed
Beds

NofStaffedBeds

“Number of Beds
that can be operated
at present staffing
levels”

ProfitStatus

Not for Profit or
Profit

HAEntityApplication HAEntityApplication

HAEntityId

“Identification

“contains the automation

number associated

information for all the

with surveyed

facilities in the database”

entity. Unique
within survey year.”
AppId

Record
identification
number

Application

Software application
name (e.g., Clinical
Data Repository,
Clinical Decision
Support System
(CDSS), etc.)

ApplicationId

Unique
identification

80
number for
application
Category

“The category the
software application
is associated with”

CategoryId

Unique
identification
number for
application category
(e.g., category id for
Electronic Medical
Record is 6)

Status

Indicates the status
of an application
(Not Automated,
Live and
Operational,
Installation in
Process,
Contacted/Not Yet
Installed, Not
Reported, To be
Replaced, Not Yet
Contracted)

ContractMonth

The month the
software application
was contracted

ContractYear

The year the
software application
was contracted
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Hospital Compare Database

Table Name

Description

Field Name

Description

dbo_vwHQI_HOSP

This table provide

Provider Number

Unique

demographic information

identification

for all hospitals in the

number

database.

Hospital Name

Hospital’s Name

State

The state where
hospital is located

Zip Code

Hospital’s Postal Zip
Code

Hospital

Ownership Status;

Ownership

Acute Care
Hospitals, Children
Hospitals, Critical
Access Hospitals.

Hospital Type

Description of
hospital type

dbo_vwHQI_HOSP_

This table provides

Provider Number

Unique

MORTALITY_REA

information about health

identification

DM_XWLK

conditions, quality

number

outcomes measures,

Hospital Name

Hospital’s Name

comparison to the

Condition

Description of health

national rate, and

conditions (e.g.,

mortality and

Heart attack, Heart

readmission rates for all

failure, Pneumonia)

hospitals in the database.

Measure Name

Description of health
quality outcomes
measures (e.g.
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Hospital 30-Day
Death (Mortality)
Rates for Heart
Attack, Hospital 30Day Readmission
Rates for Heart
Attack, Hospital 30Day Death
(Mortality) Rates for
Heart Failure,
Hospital 30-Day
Readmission Rates
for Heart Failure,
etc.)
Category

Comparison to the
national rate (Better
than U.S. National
Rate, No different
than U.S. National
Rate, Worse than
U.S. National Rate)

Mortality Rate

Hospital’s mortality
and readmission
rates.

dbo_vwHQI_HOSP_

This table provides

Provider Number

Unique

HCAHPS_MSR

information about patient

identification

experience on care and

number

patient rating items that

Hospital Name

Hospital’s Name

include nine key

HCAPS Question

Description about

dimensions:

the HCAPS survey

communication with

questions.
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doctors, communication

HCAPS

Description about

with nurses,

Answer

patients’ answer.

responsiveness of

Description

hospital staff, pain

HCAPS Answer

Answer scores for

management,

HCAPS survey

communication about

questions.

medicines, discharge
information, cleanliness
of the hospital
environment, quietness
of the hospital
environment, and
transition of care
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Hospital Compare-CMI Dataset

Table Name

Description

Field Name

Case Mix Index

This table provide

(CMI)

information about

identification

the average severity

number

of patient disease

Provider Number

Description

CMI

Unique

Case mix index

case mix in all

scores for all

hospital in the

hospitals in the

database.

database.
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Application Lists and Categories-HIMSS Analytic Database

Category

Application

Ambulatory

Ambulatory EMR

Ambulatory

Ambulatory Laboratory

Ambulatory

Ambulatory PACS

Ambulatory

Ambulatory Pharmacy

Ambulatory

Ambulatory Radiology

Ambulatory

Practice Management

Cardiology & PACS

Cardiology - Cath Lab

Cardiology & PACS

Cardiology - CT (Computerized Tomography)

Cardiology & PACS

Cardiology - Echocardiology

Cardiology & PACS

Cardiology - Intravascular Ultrasound

Cardiology & PACS

Cardiology - Nuclear Cardiology

Cardiology & PACS

Cardiology Information System

ED/Operating Room/Respiratory

Emergency Department Information System (EDIS)

ED/Operating Room/Respiratory

Operating Room (Surgery) - Peri-Operative

ED/Operating Room/Respiratory

Operating Room (Surgery) - Post-Operative

ED/Operating Room/Respiratory

Operating Room (Surgery) - Pre-Operative

ED/Operating Room/Respiratory

OR Scheduling

ED/Operating Room/Respiratory

Respiratory Care Information System

Electronic Medical Record

Clinical Data Repository

Electronic Medical Record

Clinical Decision Support

Electronic Medical Record

Computerized Practitioner Order Entry (CPOE)

Electronic Medical Record

Order Entry (Includes Order Communications)

Electronic Medical Record

Physician Documentation

Financial Decision Support

Budgeting

Financial Decision Support

Business Intelligence

Financial Decision Support

Contract Management

Financial Decision Support

Cost Accounting
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Financial Decision Support

Data Warehousing/Mining - Financial

Financial Decision Support

Executive Information System

Financial Decision Support

Financial Modeling

General Financials

Accounts Payable

General Financials

General Ledger

Health Information Management
(HIM)

Abstracting

Health Information Management
(HIM)

Chart Deficiency

Health Information Management
(HIM)

Chart Tracking/Locator

Health Information Management
(HIM)

Dictation

Health Information Management
(HIM)

Dictation with Speech Recognition

Health Information Management
(HIM)

Encoder

Health Information Management
(HIM)

In-House Transcription

Health Information Management
(HIM)

Transcription - Remote Hosted/ASP

Health Information Management
(HIM)

Document Management

Health Information Management
(HIM)

Electronic Forms

Home Health

Home Health Administrative

Home Health

Home Health Clinical

Human Resources

Benefits Administration

Human Resources

Payroll

Human Resources

Personnel Management
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Human Resources

Time and Attendance

Information Sharing

Browser

Information Sharing

DBMS

Information Sharing

Email

Information Sharing

Interface Engines

Information Sharing

Single Sign-On

Information Sharing

Turnkey Portal

Information Sharing

Web Development Tool

Information Sharing

Disaster Recovery System

Information Sharing

Encryption

Information Sharing

Firewall

Information Sharing

Spam Filter/ Spyware

Laboratory

Anatomical Pathology

Laboratory

Blood Bank

Laboratory

Laboratory Information System

Laboratory

Microbiology

Laboratory

Molecular Diagnostics

Laboratory

Outreach Services
Electronic Medication Administration Record

Nursing

(EMAR)

Nursing

Intensive Care

Nursing

Nurse Acuity

Nursing

Nurse Staffing/Scheduling

Nursing

Nursing Documentation

Nursing

Obstetrical Systems (Labor and Delivery)

Pharmacy

Pharmacy Management System

Radiology & PACS

Radiology – Angiography

Radiology & PACS

Radiology - CR (Computed Radiography)

Radiology & PACS

Radiology - CT (Computerized Tomography)

Radiology & PACS

Radiology - DF (Digital Fluoroscopy)
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Radiology & PACS

Radiology - Digital Mammography

Radiology & PACS

Radiology - DR (Digital Radiography)

Radiology & PACS

Radiology - MRI (Magnetic Resonance Imaging)

Radiology & PACS

Radiology - Nuclear Medicine

Radiology & PACS

Radiology – Orthopedic

Radiology & PACS

Radiology - US (Ultrasound)

Radiology & PACS

Radiology Information System

Revenue Cycle Management

ADT/Registration

Revenue Cycle Management

Bed Management

Revenue Cycle Management

Credit/Collections
Electronic Data Interchange (EDI) - Clearing House

Revenue Cycle Management

Vendor

Revenue Cycle Management

Enterprise Master Person Index (EMPI)

Revenue Cycle Management

Patient Billing

Revenue Cycle Management

Patient Scheduling

Financial Decision Support

Medical Necessity Checking Content

Supply Chain Management

Enterprise Resource Planning

Supply Chain Management

Materials Management

Utilization Review/Risk
Management

Case Mix Management

Utilization Review/Risk
Management

Data Warehousing/Mining - Clinical

Utilization Review/Risk
Management

Outcomes and Quality Management
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Application Automation Status
Status
Contracted/Not Yet Installed
Installation in Process
Live and Operational
Not Automated
Not Reported
Not Yet Contracted
To be Replaced
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APPENDIX C: Robustness Check Analysis Results

Table A. Estimation of the effects of the synergy between the portfolios of EMR capabilities
on healthcare quality outcomes at large U.S. Hospitals (Unbalanced Panel; 2008-2012)
Variable

HAM

HAR

HFM

HFR

PNM

PNR

PS

Order Entry

-0.02

0.13

-0.12

0.16

-0.09

0.06

0.19

CDSS

-0.26**

0.07

0.02

0.01

-0.13

0.26**

0.01

CDR

-0.08

-0.25*

0.01

-0.07

0.03

-0.02

-0.18

CPOE

-0.01

-0.15***

0.08

-0.03

-0.08

0.01

-0.34

Physician

0.04

-0.15*

-0.06

-0.17

-0.02

-0.15

-0.34

-0.12

-0.02

-0.19

-0.61

Documentation
The Synergy Between Basic EMR Capabilities
Basic EMR-No

0.05

-0.04

0.04

PD
The Synergy Between Full EMR Capabilities
Full EMR-With

-0.16*

0.19

-0.16*

0.10

-0.13

-0.15

1.83***

Hospital size

0.35*

0.07

0.18

0.32

0.33

0.21

-1.68**

Case mix index

-0.81***

-0.88**

-0.54**

-2..40***

-1.01***

-0.85**

2.80***

For-Profit

0.07

-0.29

0.12

0.25

0.10

0.14

0.46

Hospital Age

0.10

-0.07

0.18

-0.12

0.33

0.10

0.69*

Academic

0.18

0.16

-0.30

0.66***

0.11

0.92***

0.18

R-Square

0.72

0.77

0.74

0.83

0.74

0.81

0.89

F Value

7.53***

7.53***

8.86***

10.50***

8.65***

9.46***

19.66***

N

1087

962

1125

1066

1128

1068

1330

PD
Control Variables

Hospitals

Hospitals

* = significance at p < 0.10, **=p < 0.05, and ***=p < 0.01

91
Table B. Estimation of the effects of the synergy between the portfolios of EMR capabilities
on healthcare quality outcomes at large U.S. Hospitals (Balanced Panel; 2008-2012)
Variable

HAM

HAR

HFM

HFR

PNM

PNR

PS

Order Entry

-0.02

0.13

-0.04

-0.41*

0.03

0.24*

0.07

CDSS

-0.37**

0.01

0.01

0.17

0.25*

0.14

0.34

CDR

-0.11

-0.26*

-0.05

0.01

-0.05

-0.11

-0.20

CPOE

0.04

-0.15**

0.10

0.06

0.13

-0.03

0.59

Physician

0.03

-0.15*

0.04

-0.21*

-0.16

-0.01

-0.50

-0.29*

-0.07

-0.17

-0.82

Documentation
The Synergy Between Basic EMR Capabilities
Basic EMR-No

0.03

-0.04

0.02

PD
The Synergy Between Full EMR Capabilities
Full EMR- With

-0.09

0.19

0.13

0.28

-0.18

-0.12

1.71***

Hospital size

0.17

0.07

-0.08

0.29

0..26

0.12

-2.50**

Case mix index

-1.22***

-0.89**

-0.38

-2.65**

-1.87***

-0.99**

1.54

For-Profit

0.02

-0.30

0.29*

0.15

0.17

0.23*

0.87

Hospital Age

0.04

0.01

0.03

-0.15

0.01

-0.14

0.48

Academic

0.32*

0.17

-0.16

0.61

0.61*

0.93***

-0.79

R-Square

0.69

0.76

0.72

0.82

0.71

0.79

0.87

F Value

8.10***

8.41***

9.54*** 8.67***

9.33***

10.07***

19.76

N

590

600

623

624

685

617

PD
Control Variables

Hospitals

Hospitals

502

* = significance at p < 0.10, **=p < 0.05, and ***=p < 0.01
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APPENDIX D: Descriptive Statistics-Objective 2

Table A. The Descriptive Statistics of Early Adoption of CPOE, Quality Outcomes Measures,
and Hospital Characteristics.
Variables

HAM

HFR

HFM

PNM

PNR

PS

M (SD)*

M (SD)

M (SD)

M (SD)

M (SD)

M (SD)

Mortality/Readmission/

16.56

24.56

11.07

11.5

18.29

66.6

Patient Satisfaction

(1.7)

(2.15)

(1.58)

(1.9)

(1.74)

(10.2)

CPOE*

0.58

0.58

0.58

0.58

0.58

0.59

Hospital Size (Log)

5.14

3.14

5.14

5.14

5.14

5.14

(0.85)

(0.85)

(0.85)

(0.85)

(0.85)

(0.86)

3.33

3.15

3.33

3.33

3.33

3.32

(0.88)

(1.04)

(0.85)

(0.88)

(0.85)

(0.88)

1.37

1.37

1.37

1.37

1.37

1.37

(0.27)

(0.27)

(0.29)

(0.28)

(0.28)

(0.28)

3.1

3.1

3.1

4.8

3.1

3.14

(3.09)

(3.09)

(3.09)

(4.42)

(3.0)

(3.1)

Academic

.09

0.08

0.09

0.09

0.09

0.09

For-profit

0.17

0.17

0.17

0.17

0.17

0.18

Rates

Hospital Age (Log)

CMI

Maturity



The analysis includes the following automation status (live and operational, to be replaced,
installation in process, and contracted but not yet installed)



Mean and SD for continuous variables and proportional estimate for categorical variables
(CPOE, Academic, and For-profit)
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Table B. The Descriptive Statistics of Early Adoption of PD, Quality Outcomes Measures,
and Hospital Characteristics.
Variables

HAM

HFR

HFM

PNM

PNR

PS

M (SD)

M (SD)

M (SD)

M (SD)

M (SD)

M (SD)

Mortality/Readmission/ 16.18

24.56

11.05

18.09

18.30

66.6

Patient Satisfaction

(1.8)

(2.14)

(1.57)

(2.0)

(1.73)

(10.2)

PD*

0.52

0.52

0.52

0.52

0.52

0.51

NofBeds (log)

5.18

5.18

5.18

5.18

5.18

5.14

(0.84)

(0.84)

(0.84)

(0.84)

(0.84)

(0.86)

3.12

3.12

3.12

3.12

3.12

3.14

(1.03)

(1.03)

(1.03)

(1.03)

(1.03)

(1.04)

1.37

1.37

1.37

1.37

1.37

1.37

(0.27)

(0.27)

(0.27)

(0.27)

(0.27)

(0.27)

3.3

3.33

3.33

3.33

3.33

3.31

(4.05)

(4.05)

(4.05)

(4.05)

(4.05)

(4.13)

Academic

0.08

0.08

0.08

0.08

0.08

0.09

For-profit

0.17

0.17

0.17

0.17

0.17

0.17

Rates

Age (log)

CMI

Maturity



The analysis includes the following automation status (live and operational, to be replaced,
installation in process, and contracted but not yet installed)



Mean and SD for continuous variables and proportional estimate for categorical variables (PD,
Academic, and For-profit)
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APPENDIX E: Multicollinearity Test

The following table shows the results of Spearman rank correlation test for all quality
measures used in this study.
As shown in the following table, Basic EMR with PD portfolio has high multicollinearity with
PD, and Full EMR with no PD has high multicollinearity with CPOE. Both portfolios also have
high multicollinearity with Full EMR portfolio in all quality measures. We also notice that there
is multicollinearity issue between Basic EMR portfolio and CDSS. However, when we evaluate
the model, we observe that this correlation does not cause serious problems in terms of standard
errors, significant level, and coefficients amount.
HAM Measure

Mortality_READM_RATE: Represents HAM rate (Dependent variable)
Basic_EMR: Basic EMR portfolio with no PD
Basic_PD: Basic EMR portfolio with PD
Full_EMR4: full EMR portfolio with no PD
Full EMR5: full EMR portfolio with PD
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HAR Measure (Mortality_ReadM_Rate)

96
HFM Measure (Mortality_ReadM_Rate)

97
HFR Measure (Mortality_ReadM_Rate)

98
PNM Measure (Mortality_ReadM_Rate)

99
PNR Measure (Mortality_ReadM_Rate)
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APPENDIX F: The synergistic Impact using all Variables

The following tables show the result of the regression test before omitting full EMR-No PD and
basic EMR-PD portfolios from our model:
Table A. Estimation of the effects of the synergy between the portfolios of EMR capabilities
on healthcare quality outcomes at U.S. Hospitals (Unbalanced Panel; 2008-2012)
Variable

HAM

HAR

HFM

HFR

PNM

PNR

PS

Order Entry

-0.01

0.20**

-0.04

0.20

-0.19*

0.18*

-0.45

CDSS

-0.22**

0.05

0.01

-0.02

0.07

0.24**

-0.89**

CDR

-0.08

-0.20**

0.01

-0.01

0.004

-0.13

0.01

CPOE

0.25**

0.04

0.24***

-0.09

-0.05

0.01

-0.61

Physician

-0.06

-0.23**

0.004

-0.27*

0.09

-0.10

0.37

Documentation
The Synergy Between Basic EMR Capabilities
Basic EMR-

0.14

-0.11

0.08

-0.15

0.08

-0.28**

0.18

0.07

0.22**

-0.02

0.20

-0.08

0.25

-1.05**

0.12

-0.10

-0.15

1.57***

No PD
Basic EMRWith PD
The Synergy Between Full EMR Capabilities
Full EMR-

-0.03

-0.02

-0.01

With PD
Full EMR- No

-0.40*** -0.04

-0.27*** 0.01

0.13

0.07

-0.07

0.24

0.21

0.18

0.28*

-0.87

PD

Hospital size

0.12

0.23

(log)
Case mix

-0.74*** -0.55*

-0.69*** -1.89**

-0.91*** -1.0***

3.87**

0.13

0.14

0.16

0.01

index
For-Profit
Hospitals

-0.25 *

0.27*

-0.01
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Hospital Age

0.10

-0.11

0.09

-0.08

0.15

-0.01

0.87**

0.18

0.19

-0.18

0.52**

0.07

0.85***

-0.52

R-Square

0.71

0.77

0.73

0.82

0.74

0.80

0.86

F Value

7.12***

7.35***

8.54***

9.65***

8.66***

9.00***

15.15***

Cross Sections

1308

1079

1470

1401

1484

1408

1941

(log)
Academic
Hospitals

#
* = significance at p < 0.10, **=p < 0.05, and ***=p < 0.01

Table B. Estimation of the effects of the synergy between the portfolios of EMR capabilities
on healthcare quality outcomes at U.S. Hospitals (Balanced Panel; 2008-2012)
Variable

HAM

HAR

HFM

HFR

PNM

PNR

PS

Order Entry

-0.04

0.19*

-0.04

0.45***

-0.03

0.37***

-0.94*

CDSS

-0.29**

0.05

-0.01

0.12

0.24*

0.13

-0.77*

CDR

-0.21*

-0.19

-0.07

0.03

-0.06

-0.21*

-0.21

CPOE

0.30***

-0.11

0.20*

-0.11

0.02

-0.14

0.51

Physician

-0.12

-0.28**

0.07

-0.63***

-0.08

-0.18

0.17

Documentation
The Synergy Between Basic EMR Capabilities
Basic EMR-

0.14

-0.13

0.09

-0.36*

-0.02

-0.28*

0.45

0.12

0.24**

-0.10

0.48**

-0.3

0.18

-0.36

0.01

0.23

-0.02

-0.08

1.10**

-0.21*

-0.02

0.04

0.13

-0.94

No PD
Basic EMRWith PD
The Synergy Between Full EMR Capabilities
Full EMR-

-0.04

0.11

With PD
Full EMR- No
PD

-0.43*** -0.09

102
Control Variables
Hospital size

0.03

0.12

0.09

0.21

0..06

0.23

0.13

-1.01*** -1.02*** -0.51*

-2.21***

-1.36*** -4.01***

4.10***

0.09

-0.40*** 0.30**

0.17

0.28*

0.08

0.30

0.14

0.01

-0.01

-0.21

0.03

-0.02

0.51

0.29

0.17

-0.21

0.44**

0.15

0.86***

-1.43**

R-Square

0.67

0.76

0.71

0.81

0.71

0.79

0.83

F Value

7.88***

8.29***

9.30***

10.19*** 9.27***

9.77***

15.11***

Cross Sections

689

657

820

899

906

810

(log)
Case mix
index
For-Profit
Hospitals
Hospital Age
(log)
Academic
Hospitals

#
* = significance at p < 0.10, **=p < 0.05, and ***=p < 0.01
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